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Abstract
Neurological disorders have a strong negative impact on the quality of life of
affected patients, their close relatives as well as on the health economic system.
Early diagnosis associated with better treatment outcomes remain difﬁcult to
reach. Similarly, misdiagnosis is frequent and can lead to the delivery of the
wrong treatment to the patient. As a matter of fact, the therapeutic strategies
developed to treat Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), two
major neurodegenerative diseases, are unfortunately only effective for reduc-
ing the symptoms. This illustrates the lack of complete understanding of the
mechanisms underlining neurodegeneration. In this context, this thesis aims
to contribute to a precise comprehension of the synaptic transmission, at the
cellular level, by providing a biocompatible brain interface capable of collecting
neurochemicals while establishing a tight electrical connection with the cerebral
tissues.
The ﬁrst part of this thesis deals with the design and microfabrication of a novel
neural probe which includes microelectrodes and a micro-scale droplet generator
for the efﬁcient collection of extracellular ﬂuid. The design choices and the mi-
crofabrication approach are detailed while the behavior of the device is assessed
using ﬂuidic modeling. Experimental results regarding the neural probe’s mechan-
ical strength, electrical and ﬂuidic functions are then presented. In particular, the
electrode-tissue interface is assessed using impedance spectroscopy. The probe
ﬂuidic function and its ability to perform high frequency (6Hz) droplet segmented
collection in a rapidly changing environment is experimentally demonstrated.
In a second phase is reported the successful in vivo testing of the neural probe in
the framework of a pilot animal trial performed on rats. A custom microfabricated
analysis platform enabling to efﬁciently detect the content of the collected brain-
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ﬂuid samples is presented as well. In particular a microfabricated target plate
for the distribution and handling of the segmented samples during analysis is
reported. This unique approach allows to maintain the temporal history of
the ﬂow-segmented samples. Combined with Inductively Coupled (ICP)-Mass
Spectrometry (MS), the detection results show the presence in signiﬁcant quantity
of Na, Mg, K and Ca, reﬂecting the neurochemical state of the brain over time.
Quantitative measurements are demonstrated, highlighting the power of this
approach.
Simultaneous cerebral tissues electrical modulation and neurochemical recording
during periods of 15min is demonstrated in a third phase. A signiﬁcant neu-
rochemical response is detected in correlation with the electrical stimulation
periods (2 x 1min). In particular, the extracellular K+ ion concentration appears
to rise during these periods which is further conﬁrmed on each of the 3 implanted
subjects. It is stated that the electrical stimulation delivered to the tissues set
the neurons in a permanent hyperpolarized state, forcing a strong K+ ions efﬂux
towards the extracellular space.
This work sets a basis for the development of novel approaches in the detection
of malfunction in synaptic transmission. Future perspectives of this technology
include new methods enabling earlier diagnosis of neurodegenerative diseases
and more efﬁcient treatments based on a closed-loop adjustment of electrical
stimulation.
Key words: Neurotechnology, brain interface, neural probe, neuromodulation,
electrical stimulation, neurochemicals, microchannel, microelectrode, droplet,
segmented ﬂow, mass spectrometry.
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Résumé
Les maladies neurodégénératives ont un fort impact sur la qualité de vie des pa-
tients affectés, sur leurs proches ainsi que sur le système économique de la santé.
Leur diagnostic précoce, associé à des traitements plus efﬁcaces, restent un déﬁ.
Les cas de diagnostics erronés sont fréquents, entraînant parfois l’administration
du mauvais traitement aux patients. Par ailleurs, les stratégies thérapeutiques
développées pour traiter les maladies neurodégénératives sont souvent sympto-
matiques et non thérapeutiques ce qui démontre que notre compréhension des
mécanismes de neurodégénérescence est incomplète. Dans ce contexte, cette
thèse vise à contribuer au décodage précis de la transmission synaptique au
niveau cellulaire en développant une interface avec le cerveau biocompatible et
capable de mesurer des signaux neurochimiques dans les tissus tout en stimulant
électriquement ceux-ci.
La première partie de cette thèse traite de la conception et de la fabrication d’une
nouvelle sonde neuronale incluant des microélectrodes et un système de collection
du ﬂuide extracellulaire par ﬂux segmenté. Les choix de conception ainsi que
les étapes de microfabrication y sont détaillés tandis que le comportement du
système est prédit à l’aide d’un modèle microﬂuidique. Une caractérisation du
fonctionnement de la sonde est ensuite présentée. En particulier, l’interface
électrode-tissu est évaluée par spectroscopie d’impédance. La fonction ﬂuidique
de la sonde et sa capacité à effectuer une collection segmentée à haute fréquence
(6Hz) dans un environnement évoluant rapidement sont démontrées.
Dans un deuxième temps, la sonde neuronale est testée in vivo en l’implantant
dans le cerveau de rats, dans la région du striatum. Une plateforme permettant
l’analyse du contenu des échantillons collectés est également présentée. Notam-
ment, un support microfabriqué dédié à la distribution et la manipulation des
v
échantillons et leur analyse est décrit. Cette approche unique permet de maintenir
et reconstruire l’historique temporel du prélèvement de ﬂuide extracellulaire par
ﬂux segmenté. Les résultats, obtenus grâce à une analyse par spectrométrie de
masse à plasma à couplage inductif (ICP-MS), ont montré la présence signiﬁcative
de Na, Mg, K et Ca reﬂétant l’état neurochimique du cerveau au cours du temps.
Les résultats ont également put fournir des valeurs ﬁables de concentration de
certains métaux présents dans le liquide extracellulaire démontrant la puissance
de cette approche.
Finalement, la modulation électrique des tissus cérébraux et l’enregistrement
neurochimique simultané pendant des périodes de 15 min sont démontrés. Une
réponse neurochimique signiﬁcative a été détectée en corrélation avec les périodes
de stimulation électrique. Par exemple, la concentration d’ions extracellulaires K+
augmente pendant ces périodes (conﬁrmé sur 3 sujets implantés). La stimulation
électrique délivrée semble placer les neurones dans un état d’hyperpolarisation
permanente, forçant un efﬂux des ions K+ des neurones vers l’espace extracellu-
laire.
Ce travail constitue une base solide pour le développement d’approches nova-
trices dans la détection de dysfonctionnement des transmissions synaptiques. Les
perspectives futures de cette technologie comprennent de nouvelles méthodes
permettant un diagnostic plus précoce de maladies neurodégénératives et des trai-
tements plus efﬁcaces basés sur un ajustement en boucle fermée de stimulation
électrique du système nerveux.
Mots clefs : Neurotechnologie, interface cérébral, sonde neuronale, neuromo-
dulation, stimulation électrique, neurochimique, microcanaux, microélectrode,
goutte, ﬂux segmenté, spectrométrie de masse.
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Chapter 1
Introduction
Neuroscience is a fascinating ﬁeld which aims at providing insights into the
most complex organ of the human body; the brain. The brain is considered
as a great biological machine which is able to sense, react, organize, store,
regulate and create while it extensively contributes to what we collectively call
consciousness. Although numerous efforts have been made to understand, decode
and predict the mechanisms taking place in the Central Nervous System (CNS)
and Peripheral Nervous System (PNS), it still remains poorly understood. Indeed
the human cerebral cortex is a complex multi-level structure containing in average
86 billions neurons each connected to a few thousands of other neurons according
to the latest evaluation (Azevedo et al. 2009). They communicate together
and constitute a centralized control center which exert orders on the other
organs of the human body. The brain is responsible for the proper working of
major conscious functions (such as perception, motor control and learning) as
well as unconscious ones (such as breathing, cardiac or digestive regulation).
Sometimes these functions are unfortunately dis-regulated due to a progressive
loss of structure or function in the neuronal network, including neuronal death.
Neurodegenerative diseases such as AD, PD and Huntington’s Disease (HD) are
caused by such degeneration processes. These pathologies strongly affect the
direct human environment of affected patients and largely impact the society.
In this context, a thorough understanding of the mechanisms involved at the
1
Chapter 1. Introduction
cellular level can contribute to provide a better understanding of the mechanisms
causing the diseases and carries the hope to develop effective treatments against
it. Several approaches can effectively address this need and, among all of them,
neurotechnologies is a very promising one.
Neurotechnology can be deﬁned as any technology which has a fundamental
inﬂuence on how we understand the CNS or PNS functions and activities. It
also includes technologies having a repair or improvement function of the brain.
The development of effective medical treatments such as Deep Brain Stimulation
(DBS) which treats Parkinson’s disease symptoms is a famous example. The
therapy consists in implanting in the cerebral tissues a neural probe comprising
platinum (Pt) electrodes which constantly stimulate electrically a precise cerebral
region, the Subthalamic Nucleus (STN). DBS is an alternative to drug-based
treatments and is considered as an effective therapy with more than 120’000
patients implanted in the world (Fukaya et al. 2015). Cochlear implant is another
successful application of neurotechnologies. The therapy consists in the direct
electrical stimulation of the acoustic nerve in order to restore a sense of sound
to persons affected by profound or total hearing impairment. The therapy is
universally considered as a success and has been implemented in more than
320’000 patients worldwide (Gaylor et al. 2013). These two examples perfectly
illustrate the effectiveness of neurotechnologies in providing novel therapies by a
controlled interaction with the CNS and PNS.
1.1 Scope of the Thesis
Among many other features such as their biocompatibility, hermeticity and re-
duced dimensions, a very important requirement for cochlear and DBS implants
is their ability to efﬁciently communicate with the nerve cells. This highlights
the importance of understanding the inter-neuron signal transmissions taking
place in the cerebral tissues to deliver an efﬁcient therapy. At this level, the signal
transmission is regulated and driven by two distinct phenomena; electrical and
chemical impulses. The scope of this thesis is precisely to focus on the neuronal
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cells inter-communications. In this context, we take advantage of the wide range
of possibilities offered by the microtechnlogies for producing efﬁcient brain inter-
faces while remaining compatible with the size-scale of a neuronal cell (5 μm to
100 μm). A focus along the course of this work was to consider biocompatibility
as an essential requirement. Indeed limiting tissue reactions and minimizing
inﬂammation result in better device integration in implanted tissues. In particular
this guarantees to measure the expected biological effect when the experiment
involves in vivo testing in living animals. More generally, this thesis lies at the
interface between neurotechnology, biology and microtechnology.
1.2 Context
1.2.1 Microtechnology
Microtechnology is a ﬁeld which deals with systems in a size range near to the
micrometer (1 μm = 1×10−6 m). Originally the ﬁeld is born in the 1960s when
progresses performed by the semi-conductor industry allowed to propose the ﬁrst
transistors (Texas Instruments) and the integrated circuits (Kilby 1959). Not only
these inventions revolutionized the electronic industry, but the associated manu-
facturing processes allowed to improve the electronic components performances,
functionalities and reliability while reducing fabrication costs and allowing a
scale up of the production volumes (Kilby 1976). These progresses also largely
impacted the computers which could suddenly be reduced from a large volume
machine taking the space of a room to a compact portable system. Electronics
was certainly the ﬁrst domain to take advantage of the progresses realized in
microtechnology, however, almost in parallel to these evolutions, miniaturization
of mechanical components gave rise to Microelectromechanical Systems (MEMS).
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1.2.1.1 MEMS
A MEMS usually consists in an electrical system combined with actionable me-
chanical components that interact with their environment. The huge potential
of these very small machines was foreseen in the famous lecture of R. Feyman
"There is plenty of room in the bottom" (Feynman 1960). MEMS employ the same
fabrication processes (lithography, ﬁlm deposition, etching, etc) as developed
for the silicon-based semiconductor industry. A major advantage therefore lies
in the possibility to integrate micromechanical parts on the same platform than
the associated microelectrical components as part of a unique production pro-
cess. The discovery and characterization of piezoresistive materials (silicon and
germanium) in the late 1950s contributed to the development of MEMS (Smith
1954; W. Paul et al. 1955). Early in the 1960s, the Bell labs and Honeywell made
signiﬁcant progresses and published different studies about thin piezoresistive
silicon diaphragms which constituted the ﬁrst pressure sensors and strain gauges,
an early version of MEMS (Pfann et al. 1961; Tufte et al. 1962). Following
these developments, many different sensors were developed. For instance, the
accelerometer measuring vibrations, shocks and motion has been offered in a
variation of applications ranging from the shock detector for airbag deployment
to personal monitoring systems (e.g. wrist band) which measures the quality of
sleep based on the body motions during night (Ciuti et al. 2015). Other examples
of MEMS detectors include gyroscopes (position and rotation sensor) and thermal
mass ﬂow sensor (Bogue 2013). Nowadays, these systems are produced at ultra
high volume and very low cost for consumers electronics. We certainly can claim
that towards 2020 more than 2 over 3 persons in the world will carry MEMS
in their pockets since a recent study conﬁrmed the smartphone industry market
penetration to reach 70% of the world population (Carson et al. 2015).
1.2.1.2 Microﬂuidics
Microﬂuidics, a major branch of microtechnology, deals with the precise con-
trol and handling of ﬂuids. In microﬂuidic systems, ﬂuids are constrained in
sub-millimetre scale channels and driven by capillary forces or external pumps.
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Typically, the functions of such microdevices includes the displacement, the
mixing, the separation and other ﬂuidic processes. Early applications of this tech-
nology emerged at the end of the 1970s with the development of silicon inkjet
printer nozzles (Bassous et al. 1977). With the growing interest of the scientiﬁc
community for the micromanipulation of ﬂuids, micropumps and valves made
their apparition (Van de Pol et al. 1989). Soon the chemical processes usually
carried out in the laboratory were attempted to be miniaturized and performed in
a single chip platform. While the miniaturization of the ﬂuid and reagent volume
would usually not impact the molecular reactions, laws of scale for molecular
diffusion and heat transport enabled a dramatic increase in reaction efﬁciency
and throughput (Dittrich et al. 2006). These so called "Lab On Chip (LOC)"
systems started to represent a signiﬁcant technological growth at the beginning of
the 1990s when they turned out to become interesting for genomics. For instance
Desoxyribonucleic Acid (DNA) microarrays used to measure the expression of
a large number of genes are considered as an advanced LOC device providing
new opportunities for DNA diagnostics (J. Wang 2000). Nowadays microﬂuidics
and LOC devices developments are largely oriented towards the ﬁeld of "point
of care" diagnostic devices (Jung et al. 2015). These devices aims at providing
in vitro diagnostics at the site the care is given, including at home, and address
the growing need of rapid treatment associated with rapid diagnosis. Interest-
ingly, LOC have been applied to a large range of neurobiology studies such as
biochemical experimentation, morphological observations or electrophysiological
investigation (Soe et al. 2012). In particular, advances realized in microfabrica-
tion processes enabled to produce Multielectrode Arrays (MEA) which are devices
containing multiple electrodes organized in a planar conﬁguration to measure in
vitro neuronal signals. The study involving neural interfaces brought signiﬁcant
understanding to the electrophysiological processes taking place at the neuronal
network level. The application of this technology includes electrical recording
and stimulation of neuronal cells as well as drug testing and screening. Figure
1.1 (a) shows a Scanning Electron Micrography (SEM) of a neuron adhering to
pillar electrodes of a MEA whereas ﬁgure 1.1 (b) presents a general view of a
64 x 64 microelectrode array device proposed by Berdondini et al. (Zeck et al.
2001; Berdondini et al. 2009). In the future, LOC is anticipated to become a
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new paradigm of instrumentation and will probably be included in the toolbox of
the neuro-clinicians in order to support their decisions throughout the diagnosis
phase.
(a) (b)
20  μm
Figure 1.1 (a) SEM view of a neuron adhering to a set of pillar electrodes part of a MEA
(b) General architecture of a MEA device. The gold-colored area is structured with a 64 x 64
planar electrode array which are used to sense and stimulate a neuronal network (adapted
from Zeck et al. 2001; Berdondini et al. 2009)
1.2.2 Clinical Neuroscience
Clinical neuroscience is a branch of medicine which deals with various types of
neurological disorders. It is subdivided in 3 specialities; neurosurgery, psychiatry
and neurology. While neurosurgery focuses on the surgical treatment of cerebral
diseases and psychiatry is devoted to the diagnosis and treatment of mental
disorders, neurology takes care of the CNS and PNS disorders. For a physician
trained in neurology the clinical evaluation of a patient often starts with an
examination during which the assessment of the cognitive functions, motor
reﬂexes and status of cranial nerves and reﬂexes is performed. Different diagnostic
methods exist to support the initial diagnostic. We distinguish imaging methods
like Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) or
ultrasounds and neurophysiology methods such as Electroencephalography (EEG),
Electromyography (EMG), Nerve Conduction Study (NCS), evoked potentials
or lumbar puncture. All these methods largely rely on advanced technologies
facilitating the clinicians decision process whether it be during the diagnostic
phase or during surgeries.
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1.2.2.1 Neuroimaging
Neuroimaging is a relatively recent discipline in medicine which has been devel-
oped with the aim to image the inner composition of the brain at a structural and
functional level (Filler 2009). It usually follows a neurological examination made
by a physician to further investigate a patient who may present a neurological
disorder. For instance CT is a method in which multiple x-ray scans are taken in a
same plane while successively rotating the source and detector around the patient.
After image reconstruction it enables to build a virtual tissue slice of the body,
allowing the physician to literally see "inside" the patient. CT may be indicated
for the detection of traumatic brain injuries and in case of headaches (B. Lee et al.
2005; Evans 2009). A limitation to this technique may be related to the hazard
represented by the x-ray radiations, although this issue is well controlled today.
MRI produces high resolution images using strong electro-magnetic ﬁelds to
generate an image of the body inner anatomy without using x-rays. Its superior
resolution and better contrast between white and grey matter makes it the method
of choice for brain imaging and largely participates to the detection of various
cerebral conditions such as epilepsy, dementia or cerebrovascular diseases (Jordan
et al. 2014).
Ultrasonology, a technique in which sound waves reﬂected by the inner structures
of the body are measured and computed to produce an image is the method
of choice to monitor cerebrovascular and heamodynamic parameters of the
brain. The principal advantage of this method is its low cost and high temporal
resolution although it lacks resolution for the detection of soft tissues (Tsivgoulis
et al. 2016).
1.2.2.2 Clinical Neurophysiology
While neuroimaging methods provide a representation of the brain through
detailed images, sometimes the physician needs to focus more deeply on a speciﬁc
CNS or PNS function. Clinical neurophysiology concentrates on the recording
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of bioelectrical activity of the nervous tissues whether evoked or spontaneous.
It can reveal speciﬁc and precise information about the site and the extent of a
lesion or dysfunction in the nervous tissues. Among the available methods, EEG
is a non invasive procedure in which multiple electrodes placed on the scalp of a
patient measure voltage ﬂuctuations resulting from ionic currents in the upper
level neurons of the brain (cortex). It reﬂects the spontaneous activity of these
structures over time with excellent temporal resolution. EEG is used to diagnose
epilepsy and help to locate the seizure origin and propagation pattern (Michel
et al. 2012).
EMG is a method which evaluates and records the electrical activity produced
by the muscles activated by neuro-electrical impulses. This approach is often
indicated when the physician needs to detect abnormalities in the activation level
that are linked to a neuromuscular disease or to motor control disorders. EMG is
also used in motor prosthetic limb systems in order to actuate and control the
robotic device. EMG is usually performed in combination with NCS to measure
the nerve conductivity. NCS is a procedure which evaluates the conduction
velocity in motor and sensory nerves of the human body. It is minimally invasive
since the approach involves transdermal stimulation using electrodes placed on
the patient skin while conduction needles are also used for direct in vivo nerve
stimulation. NCS along with EMG are indicated when there is pain in a limb,
weaknesses due to spinal nerve compression and for the detection of some other
neurological disorders (Chichkova et al. 2010).
Evoked potentials is another method where electrical potentials are recorded
from nervous structures following the voluntary stimulus of a sense organ. Visual,
auditory and tactile stimuli are voluntarily presented to the patient in order
to elicit a CNS response. The reversed process consisting in stimulating the
nervous tissues and controlling the intended effect on a patient is practiced as
well. It is extremely useful when intraoperative neurophysiological monitoring
is required. Indeed certain crucial neural structures (spinal cord, white matter,
etc.) which need to be preserved are recorded during surgeries in order to guide
the neurosurgeons action (e.g tumor resection). This aims at extending as much
as possible the surgical treatment while limiting the risk of future neurological
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deﬁcits. The impact of such methods is high; it has permitted to signiﬁcantly
reduce the morbidity and improve the quality of life of patients treated for glioma
tumors (resective surgeries) (De Witt Hamer et al. 2012; Duffau et al. 2005).
As exposed in this chapter, clinical neuroscience largely makes use of different
imaging and bioelectric measurement methods to diagnose and treat affected
patients. The brain biochemistry accompanying cerebral disorders or injuries
can provide equally important physiological information to the clinicians during
diagnostic and post-treatment. Lumbar puncture is a complementary diagnostic
tool which consists in the collection of Cerebrospinal Fluid (CSF) with a needle
inserted into the spinal cord canal accessed from the back of the patient. The
analysis of the collected liquid gives precious information regarding the diagnosed
disease . The advantage of such an approach is that it is a relatively simple medical
procedure whereas the analysis results may, for instance, exclude infections,
inﬂammatory and neoplastic disease affecting the CNS (Sexton 2011; Shlamovitz
2007).
Similarly to lumbar puncture, cerebral microdialysis involves the sampling and
analysis of liquid collected from discrete brain locations. Here the Extracellu-
lar ﬂuid (ECF) collection is performed continuously with a microdialysis probe
inserted in the brain. A microdialysis probe consists in a catheter in which a
continuous perfusate ﬂuid circulation is performed while, at the distal tip, the
catheter contains a membrane through which ECF molecules are incorporated in
the perfusate to be later analysed. Figure 1.2 shows a market-approved cerebral
microdialysis (MD) probe system. The method allows to monitor the cerebral
energy metabolism changes over time before being detectable in the peripheral
vascular system. The recorded parameters comprise the glucose concentration
level as well as the ratio between the lactate and pyruvate metabolites which
reﬂects the mitochondrial state at the cellular level. It is widely used in neuro-
critical care units to monitor patients after cerebral ischemia (Nordström 2010).
A decrease of the glucose level and an increase in the lactate/pyruvate ratio
is associated with poor outcomes after Subarachnoid Hemorrhages (SAH) and
traumatic brain injuries (Timofeev et al. 2011). Another application of cerebral
microdialysis is the determination of the cerebral perfusion pressure optimal level
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after traumatic brain injuries (Nordstrom et al. 2003). Among the limitations of
the method we can cite the temporal resolution which is poor (typically of 10min
to 20min) and makes the method only compatible with the monitoring of slowly
occurring neurochemical changes (Bourne 2003).
Figure 1.2 (a) Cerebral microdialysis (MD) probe used in clinical settings. The system also
includes an intracranial pressure sensor (ICP) and a brain tissue oxygen sensor (O2). A
syringe pump delivers the perfusate solution to the probe and the microdialysate is collected
from the collection vial. (adapted from R. J. Shannon et al. 2013) (b) Microdialysis probe
including the shaft and the distal part of the catheter which contains the membrane. (c)
Detail and inner structure of the microdialysis catheter tip when exchanging molecules with
the ECF.
1.2.2.3 Diagnostics
As it is the case in many medical ﬁelds, a successful treatment in neurology is
only possible when an accurate diagnostic has been performed and an indication
clearly identiﬁed. As discussed in chapter 1.2.2.2, the clinical evaluation starts
with the patient examination which aims at evaluating the cognitive and motor
function. This initial step is often followed by a deeper evaluation using imaging
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or neurophysiological methods aiming at conﬁrming the presence of the disorder.
However, neurological misdiagnosis can occur; essential tremor, one of the most
common neurological disorder, gets often mistaken for PD (in 1 over 3 patient)
while epileptic patients experiencing non-convulsive seizures might be misdiag-
nosed for primary psychiatric illnesses (Jain et al. 2006; Mirsattari et al. 2011).
A retrospective study performed on more than 1100 subjects diagnosed and
treated for the Creutzfeldt-Jakob Disease (CJD) indicated that 32% of them were,
in fact, negative to prion disease (Chitravas et al. 2011). Identically, Multiple
Sclerosis (MScl) is a CNS disease reported to be commonly misdiagnosed in 10
to 15% of cases, some studies even talking about 35% (group of 366 patients)
(Poser 1997; Solomon et al. 2013). In MScl, the radiographic analysis and over-
reliance on MRI interpretation is a common contemporary mistake leading to
misdiagnosis (Solomon et al. 2013). In Functional Neurological Disease (FND)
like in MScl, the diagnosis is difﬁcult to establish since we lack understanding
in the pathophysiological mechanism involved. FND patients present normal
brain structure although they experience strong symptoms such as blackouts,
weaknesses, movement disorders and sensory symptoms (Stone et al. 2010).
These various examples demonstrate that neurological disorders might be difﬁcult
to identify resulting in undiagnosis or misdiagnosis. Consequences can be serious
as affected patients may not receive the adequate medication and appropriate
treatment. This highlights the need for better understanding and characterizing
the disorder development and propagation mechanisms. Novel tools and methods
are required in order to achieve this goal.
It is commonly known that neurodegenerative diseases begins 10 to 20 years
prior to clinical manifestation and diagnosis (Sheinerman et al. 2013; Hampel
et al. 2011). Although the molecular mechanisms behind the pathologies are
diverse, neurodegenerative diseases present common processes such as retraction
of neurites, dysfunction and destruction of synapses and ultimately neuronal
death (Bredesen 2009). It is for instance the case in AD and PD. AD is an ir-
reversible neurodegenerative disease characterized by a progressive evolution
causing memory losses at the beginning, language problems, disorientation and
loss of motivation in severe manifestations. Recent studies reports that 6% of
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persons aged over 65 are affected in the US which has a huge economical impact
on the health system (Reitz et al. 2014). In PD, the second most common neuro-
logical disorder (after AD), the symptoms usually include motor and non-motor
dysfunctions such as rest tremor, bradykinesia, rigidity and loss of postedural
reﬂexes with serious consequences on the quality of life of affected individuals
(Jankovic 2008; Wu et al. 2011). Both conditions (AD and PD) are most often
diagnosed late after the onset of the disease. In PD striatal dopamine content is
already reduced by 80% or more when clinical signs of the condition may be iden-
tiﬁed (Marsden 1990). In AD, diagnostic may be delayed because the symptoms
appear often at a moment when the patient family and close environment may
interpret the symptoms as being normal given the age of the person (Miranda
et al. 2011).
Today available medications are rather slowing down the progression course of
the neurological disorders than having a curing effect. However these treatments,
especially for PD and MScl, are more effective when started earlier, in the mild
phase, and result in a prolonged quality of life for the affected patients (Noyes et
al. 2013; Pahwa et al. 2010; Hauser 2009). Ultimately, the physicians would like
to identify asymptomatic individuals at risk for developing the disease (Petersen
2009). This shows there is a need for detection methods enabling earlier diagnosis
of neurological disorders. Early detection will probably be only possible when
associated with a better understanding of the pathophysiological mechanisms
behind the disorders.
1.2.3 Motivations
The high occurrence of misdiagnosis cases in the detection of neurological disor-
ders demonstrate that their manifestation translates in subtle symptoms which
are difﬁcult to identify. Although many progresses have been made to decode
the pathophysiological mechanisms involved in AD and PD, two major degenera-
tive diseases, we today still lack a complete understanding of the degenerative
phenomena involved. The neuroscientists need better tools than existing neuro-
physiological solutions which will eventually translate in a new detection method
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or therapy in the future. Providing a precise comprehension of the synaptic
transmission, at the cellular level, implies to understand how the neurochemically
mediated connections between neurons function and how they are affected by
the neurodegenerative action. As stated by DeKosky et al., this could allow to
address 2 major unmet needs; the identiﬁcation of effective medication for the
treatment of neurological disorders and the earlier initiation of the treatment
(DeKosky et al. 2003). The objective of this work is to develop novel methods
for performing advanced neurophysiological studies in the brain. The use of
microtechnology methods will enable to provide minimal invasive solutions by
reducing the size of the device.
1.3 State of the Art
1.3.0.1 Synaptic Transmission
The human brain is composed of 86 billions neurons forming a great network
capable of processing complex informations (Azevedo et al. 2009). A neuron
is basically composed of a soma containing the nucleus prolonged by dendrites
and an axon terminated by synapses. This speciﬁc cell is electrically excitable
and capable of propagating Action Potential (AP) to other neurons via its axon
and synapse while its dendrites serve to bring signals received by neighbouring
neurons. Transmission of information in the brain is driven by electrochemical
processes. When a neuron propagates an AP that ends-up in the synapse it stimu-
lates the release of chemical agents in the synaptic cleft, the neurotransmitters.
These neurotransmitters travel to the post-synaptic neuron and generate (or
inhibit) a new action potential as represented in ﬁgure 1.3. Besides this rather
classical description based on spatially-speciﬁc neurochemical exchanges (taking
place in the synaptic cleft) neurons may also inﬂuence themselves by "volume
transmission" consisting in a general change of molecular composition in a given
region. The continuation of an AP propagation between two neural cells depends
on the temporal and spatial summation of these multiple inputs received by the
distal neuron. As the generation and propagation of AP is due to ionic exchanges
13
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Figure 1.3 Schematic representation of signal transmission between neurons. The incoming
action potential provokes the release of endogenous chemicals, the neurotransmitters, when
reaching the synapse. Neurotransmitters diﬀuse in the synaptic cleft and reach the post
synaptic neuron to generate a new action potential. The signal transmission is based both on
electrical and chemical processes.
taking place through the neuron membrane, its depolarization has an impact on
the external medium ionic composition (Hodgkin and Katz 1949). Therefore,
extracellular recordings of the electrical potentials is an efﬁcient strategy for
monitoring the intracellular signal propagation.
1.3.1 Neural Interfaces
1.3.1.1 Wire Electrodes
As introduced in the precedent chapter the inter-neuron communication is essen-
tially based on electrochemical processes. Due to a relatively straight forward
implementation, electrical signal acquisition was the ﬁrst method explored by
the neuroscientists for interfacing neuronal cells. Probably inspired by the work
performed by Hudgkin and Huxley in their study about the conduction in nerves,
the ﬁrst in vivo devices were constituted of a glass-isolated micro Pt wire (diam-
eter in the 100 μm range) of which the conductive distal tip was the recording
site (Hodgkin and Huxley 1952; HajjHassan et al. 2008). They were developed
in the 1950s and allowed to observe and better understand in real time how a
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single neuron functions in vivo and how multiple neurons interact with each other
(Gesteland et al. 1959). Serial displacements of the wire electrode at the sensori-
motor cortex level provided deeper understanding of the brain structure function
but quickly the need for larger arrays providing multisite recording capacity
appeared. Such systems comprised ﬁrst several wires assembled together before
to be surpassed by the potential of silicon microfabricated multi-site recording
arrays (Terzuolo et al. 1961; Verzeano et al. 1960). However a particular class of
ultra small wire-electrode consisting of a single carbon ﬁbre (diameter of 7 μm)
was soon proposed as an efﬁcient neural recording device (Armstrong-James
et al. 1979). As a matter of fact carbon wire electrodes largely contributed to
the understanding of the mechanisms involved in inter-neuron communication
when they were identiﬁed as an electrochemically stable material and proposed
to perform Fast Scan Cyclic Voltametry (FSCV) in vivo (Millar et al. 1985). In this
method, cyclic voltametry is performed in cerebral tissues at very high scan speed
(up to 10−6 V/sec) and allows to monitor the release of certain neurotransmitters
with sub-second precision (Perry et al. 2009). Although the method beneﬁted
from a high temporal resolution (reaching 10Hz) it remained mainly limited to
the study of Dopamine (Da) which has a well distinguishable oxidation peak
compared to other interfering electroactives species present in brain tissues. Lat-
est technological advancements of micro-wire devices concerns the addition of
permeable 3,4-Ethylenedioxythiophene (PEDOT)-Naﬁon composite membrane or
vertically-aligned carbon nanotubes at the conducting tip allowing for selective
detection of Da or ascorbate, respectively (Xiang et al. 2014; Vreeland et al.
2015).
1.3.1.2 Silicon-based Devices
The group of Robert L. White from Stanford University pioneered when they
proposed to use integrated circuit manufacturing processes to create multielec-
trode arrays (Mercer et al. 1978). These ﬁrst devices comprised a molybdenum
substrate and Pt metalic conductors as shown in ﬁgure 1.4 (a). Soon the base ma-
terial of these devices became rigid silicon substrate with Pt-deposited electrodes.
The technology progressed and the integrated circuit became part of the recording
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device itself, allowing to provide a better decoding of the brain functions (Bragin
et al. 1995). The Utah array developed by the group of Richard A. Normann
provided for the ﬁrst time a rigid 100 channels probe grid organized in a 3D
network (Campbell et al. 1991) as shown in ﬁgure 1.4 (b). This tool was proposed
as a reliable neural interface to perform recordings and stimulation at the level of
the sensorimotor cortex (Maynard et al. 1997). Sophisticated microfabricated
(a) (b) (c)
Figure 1.4 Technological evolution of the electrical neural interfaces. (a) First reported
microfabricated molybdenum-platinum neural probes. Each probe carries 8 Pt electrodes.
(adapted from Mercer et al. 1978) (b) SEM of the Utah intracortical electrode array. The
structure integrates a 10 x 10 electrodes array arranged in a compact manner. A platinum
layer is deposited on the 1.2 mm tall tips. (adapted from Maynard et al. 1997). (c) Flexible
polymer-based multielectrode array. Polyimide is used as substrate and insulator material for
the Pt tracks. (adapted from Mercanzini, Cheung, et al. 2007)
approaches allowed for spatially differentiated analysis by taking advantage of
the multi-electrode arrays conﬁguration when used in combination with electro-
chemical FSCV measurements (Garris et al. 1997; Zachek et al. 2010). Although
the method presents an excellent temporal resolution, a limit for FSCV detection
is its restricted ﬁeld of use which remains linked to Da analysis. Interestingly,
simultaneous analysis of Da and Serotonine (5-HT) was also demonstrated to be
feasible (in a controlled analytical setup, not in vivo) despite the usual difﬁculties
to discriminate these species from Ascorbic Acid (AA) (Anastassiou et al. 2006).
A recent study proposed a material improvement with boron-doped diamond
as electrode for performing FSCV in cerebral tissues (Hébert et al. 2015). This
approach would present the advantage to be MRI compatible in the perspective
to permanently implant such a structure in the brain.
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1.3.1.3 Polymer-based Devices
As the applications for in vivo neural recording continued to grow, the neuro-
physiologists started to encounter several limitations with silicon-based devices.
Chronic injuries that were caused during implantation, brittle characteristics of sil-
icon and long-term tissue reaction severely impacted their functionality (Williams
et al. 1999). As a response to these limitations, a new category of biocompatible
polyimide-based devices integrating platinum electrodes were proposed (Metz,
Oppliger, et al. 2000; T. Stieglitz et al. 2000; Rousche et al. 2001). A major
advantage of these technologies is their mechanical ﬂexibility as illustrated in
ﬁgure 1.4 (d). A direct application appeared, the nerve cuff electrodes, which
allowed to perform neural recordings with a ﬂexible device wrapped around the
periphery of a nerve (Rodriguez et al. 2000). Inﬂammatory tissue reaction in
acute and chronic use was showed to be minimized with polyimide-platinum com-
bined devices (Mercanzini, Cheung, et al. 2007; Mercanzini, Colin, et al. 2009).
Biocompatible polymer-based neural interfaces have imposed themselves as the
material of choice for developing performant long-term implantable electrical
interfaces. The latest neural probe technology includes ultra thin, ultra ﬂexible
injectable mesh electrodes (Xie et al. 2015). The device re-conciliate the neural
probes with the basic requirements for efﬁcient chronic recording in neuronal
tissues by providing a very dense network of recording sites and a highly ﬂexible
substrate compatible with the mechanical properties of the cerebral tissues.
1.3.1.4 Fluidic Devices
In parallel to the evolution of electrical neural probes, as microfabrication meth-
ods improved, ﬂuidic microchannels were successfully integrated on electrical
neural probes. They constituted a technological "add-on" for the electrical neural
probes by providing a ﬂuidic access to the implanted tissues. The main motivation
was here to bypass the Blood Brain Barrier (BBB) which is usually a difﬁcult limit
to cross for standards drug-based approaches. A ﬁrst application was therefore to
perform drug screening with different chemical agents in the cerebral tissues by
monitoring the electrical activity response of the neurons (J. Chen et al. 1997).
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More recently, polymer-based probes combining microelectrodes and microﬂuidic
channels on the same device were presented. Altuna et al. implanted SU-8
(negative photoresist epoxy) probes in anaesthetized rat brains and demonstrated
a high correlation between drug delivery and consecutive increased electrical
activity (Altuna, Bellistri, et al. 2013). The stretchable Polydimethylsiloxane
(PDMS) device proposed by Minev et al. also demonstrated the potential of
simultaneous electrical and ﬂuidic stimulation to restore voluntary locomotion in
a rat affected by a paralyzing spinal cord injury(Minev et al. 2015).
1.3.2 Neurochemicals Monitoring
1.3.2.1 Microdialysis
As emphasized in the last chapter the ﬂuidic function of neural probes remained
mainly limited to liquid delivery in-situ. An explanation to this restricted ﬁeld of
use could be provided by the existence of another method called microdialysis.
Microdialysis probes were developed by neuroscientists for the extraction of brain
ﬂuids such as CSF. Their working principle is based on establishing a gradient of
concentration between two compartments separated by a semi-permeable mem-
brane to drive a molecular diffusion inside the probe. Their successful operation
for quantifying molecule levels in neuronal tissue demonstrated by Ungerstedt
et al. contributed signiﬁcantly to the use of this method in neuroscience (Ljung-
berg et al. 1978; Zetterstrom et al. 1984). These devices were largely used for
the monitoring of neuromodulators concentration in cerebral tissues. The role
of adenosine in mediating sleep was decoded using microdialysis. It revealed
that the adenosine concentration in ECF increases during long-lasting awake
periods while it tends to restore during sleep periods (Porkka-Heiskanen et al.
1997). Microdialysis was also used to establish the link existing between the
glutamate concentration rise following brain ischemia and its probable toxic effect
on cerebral tissues (Benveniste et al. 1984). Although promising application were
developed using microdialysis probes they present some major limitations. The
probes are still relatively large with a typical diameter of 200 μm to 400 μm and
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a sampling length of 1mm to 4mm, thus drastically limiting spatial resolution
when recording in cerebral tissues (Kennedy 2013). Furthermore, the temporal
resolution achieved with these systems is limited to 10 to 20 minutes which make
them incompatible with the time scale of the neurochemical exchanges taking
place inbetween neurons (Aris 1956; Kennedy 2013).
1.3.2.2 Push-pull Perfusion
Push-pull perfusion is an in vivo sampling method consisting in perfusing a ﬂuid in
the tissues with a micro cannulae while re-collecting the same ﬂuid with another
adjacent cannulae; the perfusate being for a short period of time in direct contact
with the ECF tissues. The method was ﬁrst reported in 1961 by J. Gadhum
and used in vivo to perform biochemichal behavior studies (Tilson et al. 1970).
These systems were ﬁrst operated at high ﬂow rate (∼50 μLmin−1 to 200 μLmin−1)
resulting in substantial lesions to the brain tissues (Redgrave 1977; Cepeda et al.
2015). Low-ﬂow push-pull perfusion (<50 nL/min) was demonstrated to be less
invasive than currently available microdialysis options (Cepeda et al. 2015). The
ﬁrst low-ﬂow push-pull perfusion devices introduced consisted in concentrically
assembled capillary tubing while, only recently, the group of R.Kennedy proposed
a microfabricated push-pull device (Kottegoda et al. 2002; W. H. Lee, Thomas R.
Slaney, et al. 2013). The latest evolution of this device consisted in incorporating
a nanoporous membrane at the at the tip of the probe thus turning the system
into a microdialysis application and loosing spatial resolution (the sampling zone
is 4mm long) (W. H. Lee, Ngernsutivorakul, et al. 2016).
1.4 Thesis Positioning
1.4.1 Thesis Objectives
The comprehension of the phenomena involved at the neuronal level implies both
a thorough understanding of the electrical and chemical processes involved. The
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understanding of the interplay between electrical processes and correlated chemi-
cal processes is equally important. Implanted minimally invasive approaches are
preferable for the collection of relevant and precise information at the cellular
level. As highlighted in the state of the art (1.3), there are today only a few
devices combining the features of chemical and electrical interactions. Further-
more, their ﬁeld of use has been limited to ﬂuidic delivery and simultaneous
electrical recording (sometimes stimulation) which is very limiting. Today a
method allowing for a reliable electrical interface with the cerebral tissues and a
direct access to the brain metabolites overpassing the low spatial and temporal
limitations of the microdialysis is missing.
The objective of this thesis is to address this limitation and contribute to the ﬁeld
of electrophysiology by developing new interaction strategies with the cerebral
tissues. The implementation of microfabrication methods for the integration of
electrical and microﬂuidic features on the same device will allow to perform
precise, time-resolved, neurochemicals collection while remaining in close prox-
imity to the tissues. This work further explores the versatility provided by the
MS analysis method for the detection of the molecules extracted from brain-ﬂuid
samples.
More generally, such a tool could be a great platform for completing our un-
derstanding of the brain functions. It is thought that introducing combined
interaction functions (chemical and electrical) could potentially lead to the de-
velopment of new therapies. Today’s existing therapies such as DBS or cochlear
stimulation are exclusively based on electrical neuromodulation which is prob-
ably limiting the extent of the therapeutic effect. As presented in this chapter,
diagnosis of neurological disorders can be challenging with the current methods.
This work sets a basis for the development of novel approaches in the detection of
malfunctioning synaptic transmission. Future application of the technology could
enable earlier diagnosis of neurodegenerative diseases with a probable impact on
extending the quality of life of affected patients.
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1.4.2 Thesis Structure
The ﬁrst part of this work deals with the design and microfabrication of the neural
probe and with the functional testing of the device (chapter 2 and 3). In a second
phase is reported the ﬁrst in vivo testing of the probe in the framework of a pilot
animal trial performed on rats (chapter 4). The detection method implemented in
order to analyze the collected samples is detailed in this section as well. The third
part deals with the second in vivo trial of the neural probe where neurochemical
response to electrical stimulation of cerebral tissues is investigated (chapter 5).
21

Chapter 2
Neural Probe - Design and
Development
This chapter addresses the main topics which enabled the design and development
of the neural probe. It begins with a list of requirements regarding the functions to
be integrated into this device which will further guide its development throughout
this work. Then theoretical considerations for microﬂuidics and microelectrodes
design are made before introducing the characteristics and features of the neural
probe. Its advanced microfabrication method is described while providing some
details regarding process optimization. This chapter closes with the description of
a microﬂuidic model of the probe allowing to predict the behavior of the system.
It is worth mentioning this chapter is partly inspired from a scientiﬁc article
recently published by the author (Petit-Pierre et al. 2016).
2.1 Design Considerations
2.1.1 System Requirements
In medical device development, the project starts with the deﬁnition of the User
Requirements Speciﬁcations (URS) and Product Requirements Speciﬁcations
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(PRS), based on the intended use and the needs of the ﬁnal equipment user. In
the context of this work, the requirements answer to the speciﬁc needs of the
neuroscientist in term of interaction possibilities with the neuronal environment
(electrical and ﬂuidic) and in term of connections to the control and measurement
systems (existing equipments). As discussed in chapter 1, the neural probe will
include:
1. Microchannels for ECF collection
2. Microelectrodes for neuromodulation and neural recording
Starting from there, table 2.1 shows a set of requirements which have been
deﬁned and respected along the development course of the neural probe.
Among the most important requirements such as the system spatial and temporal
resolution, the probe biocompatibility requirement is a major element which
guided the design. Indeed the probe is intended to be inserted in cerebral tissues
and should limit body reaction such as inﬂammation or ﬁbrosis. Even if the device
is intended to be used in an acute application 1, maximal care should be given to
minimize the local reaction of the brain which could impact the measurements.
The structure of the probe includes Polyimide (PI), SU-8, Pt and Ti. PI is well
known for its excellent biocompatibility associated with its good mechanical
properties (Richardson et al. 1993; Y. Sun et al. 2009; Seo et al. 2004). SU-8 is
an epoxy photoresist which also demonstrates good biocompatibility properties
(Nemani et al. 2013; Cho et al. 2008). Pt and Ti are considered as biocompatible
metals; Pt is widly used as electrode materials for pacemakers, DBS systems or
cochlear implants while Ti is traditionally used for Implantable Pulse Generator
(IPG) casings or orthopaedic implants.
In addition to the precedent considerations, the system must be compatible with
a reliable detection method suitable for low volume ﬂuid samples (in the order
of tens of nanoliter). The chosen analytical method should provide detailed
information regarding the sample contents, in particular it should provide access
1In medical devices development, the mention "long term" relates to an implantation time over
29 days (FDA deﬁnition) (Sall 2013)
24
2.1. Design Considerations
Table 2.1 Set of basic requirements deﬁned for the development of the neural probe.
# Requirements Description Type
1. Indication for use
1.0 Intended use The device shall ensure the collection of
ﬂuid and the delivery of electrical stimula-
tion to the neuronal tissues
must
1.1 Short term The device is operated in an acute mode
(single use)
must
1.1 Long term The device should be compatible with long
term implantation
should
2. Physical dimensions and conﬁguration
2.0 Size Device implanted tip does not exceed a
section area of 250 μm x 250 μm
must
2.1 Fluidic interaction The device includes a microﬂuidic system
for neurochemical sampling
must
2.2 Electrical interaction The device includes microelectrodes for
tissues neuromodulation and recording
must
2.3 Proximal connecting zone The device includes a proximal connection
zone to couple with the ﬂuidic and electri-
cal driving/recording equipment
must
3. Materials
3.0 Biocompatibility Materials in contact with the tissues should
be biocompatible and limit tissues reaction
must
4. Performances - mechanical/electrical/ﬂuidics
4.0 Temporal resolution The system provides a method for sam-
pling at high temporal resolution
must
4.1 Spatial resolution Every probe tip active elements are situ-
ated on the same surface in close proxim-
ity
must
4.2 Device life-time The system shall remain functional for at
least 2 h of continuous operation
must
4.3 Mechanical strength The device tensile, compression and bend-
ing strength shall be sufﬁcient to ensure
its integrity during normal handling
must
4.4 Electrical conduction The device electrical tracks shall have a
low Direct Current (DC) resistance to prop-
erly conduct electrical signals to/from the
microelectrodes
must
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to the molecular information in direct relationship with the neuronal exchanges
taking place in the brain (ionic species involved, neurotransmitters, signaling
proteins, etc). Finally, the method must demonstrate high sensitivity and a low
detection limits without being affected by the high content of salts which will
probably be contained in the brain samples.
2.1.2 Microﬂuidics - Theoretical Basis
2.1.2.1 Basic Laws
The physical properties of microsystems are subjected to subsequent behaviour
change compared to larger scale system. This can somehow be unintuitive. For
instance, if we consider the ratio between volume forces, such as the gravity, and
the surface forces, such as surface tension, the scaling law of this relation can be
expressed by:
surface forces
volume forces
= l
2
l3
= l−1 lim
x→ 0→∞ (2.1)
where l (m) is a characteristic length of the system. Equation 2.1 shows that the
volume forces becomes largely unimportant when scaling down to the microscale.
Instead surface forces becomes dominant. This must be taken into account when
designing microﬂuidic systems.
In ﬂuid mechanics, the Reynolds Number (Re) is a dimensionless quantity which
is important for predicting the ﬂow pattern of a given ﬂuid in different ﬂow
conditions. Re is deﬁned as the ratio between the inertial forces to the viscous
forces of a ﬂuid as it reads in the following relation:
Re = ρV L0
η
(2.2)
where ρ (kg/m3) is the ﬂuid density, V (m/s2) the average ﬂuid velocity, L0 (m)
is a relevant length of the system and η (Pas) is the ﬂuid viscosity. Re calculation
is relevant for ﬁnding the transition from a laminar to a turbulent ﬂow regime.
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At microscale though, the ﬂow of a ﬂuid through a microchannel is characterized
by a low Re (often Re < 1) (Bruus 2008). At low Re number, the ﬂow remains
laminar which means no turbulence can be created in this regime. The particles
transported in a ﬂuid can therefore be transported with a relative predictable
manner. An impacting consequence for microﬂuidic manipulation is that the
mixing can be difﬁcult to perform; two adjacent ﬂows meeting in a single channel
will remain separated, for instance.
Poiseuille (or Hagen-Poiseuille) ﬂow describes the pressure driven ﬂow in a
channel at steady-state conditions. It derives from a class of solutions to the
Navier-Stokes equation (assumptions: incompressible and newtonian ﬂuid) and
is of major importance to describe the basic behavior of ﬂuid manipulation in
microchannel networks and LOC systems. When a ﬂuid is driven through a long,
straight and rigid channel, the resulting pressure drop ΔP (Pa) from the ﬂow Q
(m3/s) is described by:
ΔP =R ·Q (2.3)
ΔP = 8ηL
πr 4
·Q for circular cross section (2.4)
ΔP = 12ηL
wh3(1−0.630 hw )
·Q for rectangular cross section (2.5)
Relation 2.3 indicates the ﬂow is proportional to the ﬂuidic resistance R of a
channel for a given pressure drop along the same channel. The ﬂuidic resistance
is dependent on the channel cross section geometry and length L (m). In equation
2.4, R is deﬁned for a circular channel geometry of radius r (m) while in 2.5, R
is given for a rectangular cross section of width w (m) and height h (m) (with
h <w). The latter is commonly used in microﬂuidic design because most of the
channels are realized using photolithography methods resulting in channels of
rectangular cross section.
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In a Poiseuille ﬂow, the ﬂow vx(z) has a parabolic proﬁle as expressed in the fol-
lowing relation, a solution to the Navier-Stokes equation taking into consideration
the no-slip conditions at the channel walls:
vx(z)= ΔP
2ηL
(h− z)z (2.6)
where two parallel and ﬁxed plates of inﬁnite width and of length L (m) subjected
to a pressure drop ΔP were considered (Bruus 2008). This parabolic ﬂow is
represented in ﬁgure 2.1 in an xz-plane, the system being invariant in the y
direction.
x
z
L
h PP + ΔP vx(z) 
Figure 2.1 Representation of a Poiseuille ﬂow in an xz-plane of two parallel plates spaced by
h, with a inﬁnite dimension in the y direction. The ﬂuid is ﬂowing through the channel in the
x direction due to a pressure diﬀerence of ΔP over the distance L.
The Poiseuille equations (2.3, 2.4, 2.5) indicate the ﬂuidic resistance R is linearly
dependent on the channel length L. However, R is quadratically dependent on the
cross section area of the channel. These elements are impacting the microﬂuidic
driving equipment; long channel of small cross section area can require a huge
pressure difference to establish a ﬂow.
In neural probe technology, microﬂuidic channels are still an excellent option for
establishing a precise chemical interaction with the tissues. Successful integration
of microﬂuidic channels in polymer-based neural devices were recently demon-
strated by several groups (Altuna, Bellistri, et al. 2013; Minev et al. 2015). In
these examples the microﬂuidic channels were used in order to perfuse drugs in
the medium. One can also envision to use microchannels to sample molecules
from the tissues as it is the case in microdialysis. An issue with this method is
the Taylor dispersion occurring in the sampling tube which limits the temporal
resolution that can be achieved (Aris 1956). Taylor dispersion is an effect in
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which a ﬁnite distribution of solute in a liquid ﬂowing through a tube tends to
spread under the combined action of molecular diffusion and the variation of
velocity over the cross-section (Taylor 1953). A representation of this effect is
shown in ﬁgure 2.2. Figure 2.2 (a) shows the initial conﬁguration (t = 0) of
a considered homogeneous band of solute (represented in dark gray). If the
molecular diffusion is neglected the plug gets stretched around a paraboloid
shape as it is subjected to a steady Poiseuille ﬂow v oriented along the x axis
as showed in ﬁgure 2.2 (b). The molecular diffusion driven by concentration
gradients tends to counteract the longitudinal spreading: in the front end it brings
solute particles towards the channel wall whereas at the front back it brings the
particles near the center (z axis). The deformed solute shape gets evened out and
is enlarged compared to the initial compact conﬁguration as represented in ﬁgure
2.2 (c). As a consequence the temporal history of the solute is distorted which
results in a loss of resolution.
(a)
(b)
(c)
x
z
v
v
v
Figure 2.2 Sketch of the Taylor dispersion that occurs in a cylindrical tube subjected to a
steady Poiseuille ﬂow v along the x axis.(a) Initial condition; the solute is compact and
homogeneous. (b) After a while, the solute tends to disperse in a paraboloid shape. (c)
Under radial molecular diﬀusion indicated by the vertical arrows, the solute is evened out and
enlarged compared to the initial situation.
An answer to the Taylor dispersion issue could be found in the implementation of
segmented ﬂows and droplets transport within the probe microﬂuidic channels.
The segmentation of the collected liquid by a non-aqueous phase limits Taylor
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dispersion because each droplet includes a sub-sample enclosed in a deﬁned
space. If the droplet is conserved in the same state and does not fuse with another
one during the transportation to the analysis spot, the temporal resolution of the
sampling, deﬁned by the time between two generated droplets, is maintained.
2.1.2.2 Droplet Microﬂuidics
Tremendous work on droplet microﬂuidics has been carried out with the perspec-
tive to use this method for Lab-on-a-Chip applications. Droplets microﬂuidics
is based on the separation of a continuous phase by sections of an immiscible
ﬂuid or by gas bubbles. One of the motivations in developing this technology
was to avoid axial dispersion occurring in non-segmented ﬂows (Seemann et al.
2011). Several ways to generate droplets were demonstrated. With the T-junction
conﬁguration, the break-up of a continuous stream is caused by the meeting
with a second perpendicular immiscible stream and the consequent shear stress
generated as showed in ﬁgure 2.3 (a) (Song et al. 2003). Figure 2.3 (b) shows
another method called ﬂow-focusing which uses two streams of continuous phase
to narrow a perpendicular dispersed liquid in a cross junction until the pinch-off
takes place (Anna et al. 2003). These methods are of particular interest when
combined with biological applications.
oil
(a)
aqueous
oil
oil
(b)
aqueous
T-junction Flow focusing
Figure 2.3 (a) In the T-junction conﬁguration, droplets are generated when a continuous
aqueous stream meets a perpendicular immiscible phase. (b) In the ﬂow-focusing method,
two opposed streams meet a perpendicular aqueous phase which is narrowed until the
creation of droplets.
The chemistrode presented by Chen et al. typically combines the ﬁeld of droplet
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microﬂuidics with biology (D. Chen et al. 2008). This device aims to manipulate
chemical signals instead of electrical signals as usually done with electrodes. The
chemistrode includes PDMS V-shaped microchannels. It uses droplets surrounded
by an oil carrier phase in order to deliver or record molecular signals to/from
a biological substrate such as a cell or tissues. Although the chemistrode opens
new perspectives regarding chemical interaction, it is however not designed
with implantable grade material and therefore excludes in vivo neurological
applications. In another application, Slaney et al. presented a push-pull probe
combining microdialyisis with droplets segmentation (T. R. Slaney et al. 2011).
In their approach, after the extraction, the liquid was separated by an oil phase
which improved temporal resolution and facilitated the analysis of the samples.
However, this method required the development of an external segmentation
device connected to the output ﬂow of the probe. Furthermore, it does not address
the diffusion which still occurs between the sampling spot and the generation of
the droplets.
2.1.3 Microelectrode - Theoretical Basis
2.1.3.1 Tissue-electrode interface
Microelectrodes as electrical neural interface have been extensively studied in the
past 60 years. They can take various shapes, from the single Pt wire to ﬂexible
multi-electrode arrays. The electrode-tissue interface is usually characterized
using impedance spectroscopy (Metz, Bertsch, et al. 2004; Mercanzini, Colin,
et al. 2009; Altuna, Menendez de la Prida, et al. 2012). Impedance is an electrical
measure of a system resistance to the passage of an alternative current. It is
deﬁned as the quotient between an applied potential V (t ) varying with the time t
(typically a sinusoidal variation) and its resulting current I (t ). When written as
complex values, the relation reads:
Z ( f )= V (t )
I (t )
(2.7)
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where f is the oscillation frequency. For simpliﬁcation purpose, sinusoidal volt-
ages and currents can be written as a complex function where their real part is
the actual voltage and current. Consequently, they are expressed by:
V (t )=V0ei2π f t (2.8)
I (t )= I0ei (2π f t−θ) (2.9)
where i is the imaginary number, V0 and I0 are the voltage and current amplitude,
respectively, and θ the phase shift between the voltage and current. The complex
expression of impedance Z becomes:
Z = V0
I0
eiθ =| Z | eiθ (2.10)
where | Z |, the impedance modulus, is the ratio between the current and voltage
amplitude whereas the impedance phase θ represents the phase shift between
them. Relation 2.10 can also be written as:
Z =R+ i ·X (2.11)
where R, the real part, is called the resistance and represents the opposition to
the current in the situation where no shift between the voltage and current occurs.
X , the imaginary part, is the reactance and contributes when a shift occurs. In
electrodes in contact to biological tissues, this shift is mainly capacitive; it repre-
sents the ability of a material or biological matter to store charges. Impedance
spectroscopy is the measurement of the impedance value for a wide range of
frequencies for a given system. This provides a comprehensive understanding
of the electrode-tissue electrical interaction. Impedance is often represented in
a Bode plot (log(| Z |) vs. log( f ) and θ vs. log( f )), the frequency range being
generally comprised between 100Hz and 1×107 Hz. Figure 2.4 (c) shows a typ-
ical impedance spectroscopy plot (| Z | and θ) recorded with 50 μm circular Pt
electrodes introduced in a mouse brain tissues (Béduer et al. 2015).
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A metal placed in an electrolytic environment such as the brain ECF is subjected
to chemical reactions, oxidation and reduction, involving the medium ions and
the metal electrode. This results in the accumulation of charges at the elec-
trode surface and in the accumulation of ions in the solution, in close proximity
to the metal surface. This speciﬁc arrangement is called an electrical double
layer. Although the formal electrical description of the double layer consists in
a Helmholtz capacitance CH in series with a Gouy-Chapman capacitance CGC,
experimental results have shown that a Constant Phase Element (CPE) is a good
model of this interface. Electrode surface micro-geometry (roughness) gives rise
to a fractal electrical equivalent model composed of a combination of resistances
and capacitances (Levie 1965). This fractal conﬁguration is better described by a
CPE than a capacitance. A thorough description of the metal-tissue/electrolyte
interface would also take into consideration electrochemical exchanges occurring
at the electrode surface in a non-equilibrium situation. In particular, a resistance
to the charge-transfer process (RCT) and a Warburg impedance (ZW) representing
the ions accumulated or depleted in proximity with the electrode are sometimes
considered. This subject will not be covered in detail here but the interested
reader is refered to (Kovacs 1994).
A typical electrode-tissue interface conﬁguration is represented in ﬁgure 2.4 (a).
The model elements comprise; (i) a neural probe made of a dielectric insulating
material (light orange) and a metal electrode (yellow), (ii) the neuronal tissue
(light grey). In ﬁgure 2.4 (b) an equivalent electrical circuit from the probe
microelectrode to a large counter electrode models the interface. In particular,
the tissue electrical resistance Rbulk is arranged in series with the CPE while a
dielectric capacitance Cdielectric (probe insulation) is mounted in parallel to the
ﬁrst two elements. Figure 2.4 (c) is a typical impedance spectrum of such a system
recorded with a circular Pt microelectrode (diameter d = 50 μm) implanted in
cerebral tissues of a mouse (adapted from Béduer et al. 2015). We note the
system impedance (| Z |) is capacitive at low frequencies (from f = 100Hz to
1×105 Hz) before reaching a resistive plateau (at f = 1.5×105 Hz) matching with
the moment the phase is closest to zero. At this point, the impedance value
corresponds to the external tissue resistance, Rbulk, as described by the Peak
Resistance Frequency (PRF) method (Mercanzini, Colin, et al. 2009; Béduer et al.
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2015).
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Figure 2.4 (a) Representation of the tissue-probe interface with the diﬀerent contributing
elements. The probe is made of a dielectric material (light orange) on which is patterned an
electrode in contact with the tissues (yellow). Rbulk is the tissues resistance, C is the
dielectric capacitance between the metal trace (isolated) and the tissue and Zinterface
represents the tissue-electrode impedance. (b) Equivalent electrical model. Zinterface is
represented by a CPE, which best describes the electrode-tissue interface at the considered
frequencies. (c) Typical impedance spectrum recorded from a mouse brain (adapted from
Béduer et al. 2015)
34
2.1. Design Considerations
2.1.3.2 Electrode Geometry
The geometrical conﬁguration of an electrode determines the principal charac-
teristics of the electrical interaction with the tissues. We distinguish monopolar
(or unipolar) microelectrodes from multipolar electrodes. Monopolar microelec-
trodes are electrodes in the microscale range (main dimension from 10 μm to
50 μm, in general) connected to a much larger counter electrode via a conductive
medium (such as biological tissues). Monopolar circular electrodes are the most
represented in neural probe technology (Mercanzini, Colin, et al. 2009; Altuna,
Bellistri, et al. 2013; Béduer et al. 2015). The bipolar electrode denomination is
used when an electrode is connected to a single adjacent electrode, the multipolar
denomination when an electrode is connected to multiple adjacent electrodes.
Planar circular microelectrodes are well represented in neural interfaces as (i) this
geometry is well compatible with the microfabrication processes which further
allows to minimize electrode surface roughness and (ii) they are axis-symmetrical
thus avoiding any charge accumulation at edges.
In monopolar conﬁguration, the current density is mainly concentrated in direct
proximity to the electrode and diverge in the tissue as represented in ﬁgure 2.5 (a).
The consequence of this inhomogeneous current density distribution is that almost
all the contribution to the impedance is provided by a small tissue volume nearby
the electrode. The current and potential lines produced by a planar monopolar
disc electrode of radius a, electrically isolated on its border, submerged in an
inﬁnite biological medium and exposed to a half-spherical counter electrode
placed at inﬁnite distance has been reported by Newman in 1966 as showed
in ﬁgure 2.5 (b) (adapted from Newman 1966). In this description, rotational
elliptic coordinates have been used and deﬁned as follow:
z = aξτ (2.12)
r = a
√
(1+ξ2)(1−τ2) (2.13)
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where a is the electrode radius, z is the normal distance to the electrode, r is the
distance to the axis of symmetry of the system, ξ are equipotential lines and τ are
the current lines. Laplace’s equation can be solved analytically in this system of
coordinates and gives rise to the following expression for the potential Φz:
Φz
Φ0
= 1− 2
π
arctan(ξ) (2.14)
where Φ0 is the potential at the electrode surface (Φz = Φ0 at ξ = 0) (Newman
1966). In ﬁgure 2.5 (c), ΦzΦ0 was computed for a 10 μm radius disc electrode and
for τ = 1; the current line orthogonal to the disc electrode. A rapid decrease
of the potential is observed; at z =10 μm (= electrode radius) the potential is
decreased by 50% whereas at z =63 μm, the potential is decrease by 90 %. This
means that almost 90% of tissue contribution to the impedance is produced by
a half sphere of tissue of a radius equivalent to 3x the electrode diameter. For
recording as for stimulation applications, one must take into account that the
volume of tissues which is either recorded or stimulated is in the same order of
magnitude than the electrode main dimension.
2.1.3.3 Electrode Materials
The most comprehensive experience regarding the use of implantable electrode is
related to the cardiac pacemakers that have been used in clinical practice for more
than 50 years. Neuromodulation applications such as DBS greatly beneﬁted from
the experience gathered in this ﬁeld, especially regarding the electrode materials
and their stability in the body. In term of electrode material, we distinguish noble
metal electrodes such as Pt from non-noble metal like stainless steel. An important
electrode material characteristic is the maximum charge delivery capacity QCDC.
QCDC is a measure of all the reactions that contribute to the charge transfer from
an electrode to an electrolyte; it is deﬁned as the area under the voltage-current
curve (also voltamogram) recorded in a cyclic voltammetry setup. This value also
includes any effects (and technologies) which inﬂuence the surface roughness
of an electrode thereby modifying its active area. QCDC values obtained from
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Figure 2.5 (a) Dispersion of current lines in the tissues from a microelectrode to a counter
electrode placed at an inﬁnite distance and whose surface is inﬁnitely large. (b) Analytical
solutions to the current and potential lines generated by a planar monopolar electrically
insulated disc electrode placed in an inﬁnite biological medium and opposed to a half
spherical counter electrode placed at the inﬁnite. τ are the current lines, ΦΦ0 the equipotential
lines (adapted from Newman 1966). (c) Potential drop (relative to Φ0) perpendicular to a
disc electrode (current line τ = 1) of radius r = 10 μm. The tissues potential contribution is
reduced by 50 % at a distance equivalent to the microelectrode radius.
pulse tests2 for gold, stainless steel and platinum are given in the table 2.2
(Stieglitz 2004). Among the noble metals such as gold, platinum and iridium,
platinum (Pt) and its alloys are certainly the most widely used for implantable
2Common electrode characterization test investigating the electrode behavior under real
stimulation conditions. The interested reader is referred to chapter 6.3 of the reference (Stieglitz
2004) for a complete description.
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Table 2.2 Maximum charge delivery capacity QCDC for several electrode materials (Stieglitz
2004)
Electrode material Maximum Charge Delivery
Capacity QCDC (μCcm−2)
Gold 20
Stainless steel 50
Platinum 75
electrodes. Pt charge delivery and injection capacity is well characterized. The
chemical reactions occurring at the interface with a saline solution includes the
chemically reversible charging process of the double-layer as well as electrode
surface oxidation or reduction. Generally, a maximum allowed electrode charge
density of 50 μCcm−2 is admitted to remain in the safe limit in implantable use
(Fontaine et al. 2009; Grill 2005). Under this threshold, neither corrosion nor
plating of Pt occurs.
Common non-noble metals for electrode material include the stainless steel 316
LVM, a nickel-cobalt alloy also called Elgiloy, and the MP35N, a cobalt-nickel-
chromium-molybdenum alloy. A characteristic of these metals is that they form
a passive ﬁlm at their surface to protect from corrosion. When they are used to
stimulate the tissues they inject charges by Faradic processes involving oxidation
and reduction of this protective layer. Corrosion occurs if the material is driven
above its safe charge injection limit resulting in the breakdown of the passive
layer. In this undesired situation the metal dissolves in the solution while the
water is hydrolyzed resulting in electrode failure and degradation of the biological
tissues. In noble metals this phenomenon is very limited compared to non-noble
metals, which may explain why Pt is a common implantable electrode material.
The goal of this subsection was to brieﬂy introduce some material notions in
implantable electrodes. For further details, the interested reader is referred to the
book chapter written by Thomas Stieglitz where a thorough description regard-
ing electrode materials for recording and stimulation application is presented
(Stieglitz 2004).
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2.2 Neural Probe - Geometry and Functions
In the following, we propose a novel concept of neural probe integrating Pt
electrodes and a microﬂuidic T-junction in the distal tip. The collection system
allows for a controlled sampling of ﬂuid in droplets (nanoliter range) separated
by non-aqueous segments. This approach solves the diffusion problem occurring
from the collection point to the analysis of the sample. It allows for a fast
sampling rate and therefore a high temporal resolution (under the second). As
mentioned in chapter 1, microfabrication methods can be employed in order
to address the speciﬁc requirements regarding size and biocompatibility of the
device. Working with micro-scale devices brings the question of the connectivity
with the macro-environment. Microelectrodes with a thickness of a few tens
of nanometers deposited on ﬂexible polymers can be challenging to connect to
electrical wire in the millimeter range. Therefore, the design of the probe will
include the development of an interface unit to join the macro and the micro
environment. A block diagram representing the elements included in the device
is shown in ﬁgure 2.6. The neural probe is a central element of this architecture;
its distal tip (probe active area) is intended to be implanted in the tissues while
its proximal side (probe connective area) is intended to be connected to the
microﬂuidic and electrical control units.
Probe connective areaProbe active area
Microfluidic control
Electrical control
Implanted Extra-tissue
Figure 2.6 Block diagram of the neural probe. Only the tip of the probe will be implanted
in the tissues. The extra-tissue region includes the connective zone which serves of interface
with the microﬂuidic and electrical control.
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Figure 2.7 (a) shows a top view of the probe as well as its main dimensions. The
elongated probe tip presents the advantage to leave some space between the
animal and the connective zone during the in vivo manipulations. The proximal
zone contains the electrical contacts as well as 2 ﬂuidic entries, an inlet and an
outlet, situated at the extremity of each probe leg as shown in ﬁgure 2.7 (b)
(details B and C). Figure 2.7 (b) shows the microchannels path (orange continuous
line) which connects the proximal ﬂuidic inlet and outlet to the sampling inlet
included at the distal tip, as pointed out in detail A. There, the u-shape path of
the channel meets with the probe tip inlet in a T-junction conﬁguration.
45.5 mm
10 mm
 electrical contacts (8x)
microfluidic inletmicrofluidic channel pathsampling inlet
(a)
(b)
A
B
C
microfluidic outlet
DISTAL PROXIMAL
probe legsprobe tip
Figure 2.7 (a) Overall neural probe dimensions. The proximal contacts are electrically
connected to the probe tip microelectrodes whereas the microﬂuidic network is represented
in orange (b) Detail of the 3 ﬂuidic entries of the probe; at the tip (A), the proximal outlet
(B) and inlet (C). The black arrows indicate the ﬂow direction.
The probe tip region is detailed in ﬁgure 2.8. Figure 2.8 (a) shows the circular
microelectrodes spatial conﬁguration and their dimension. We note the round-
shaped probe tip designed for an atraumatic insertion in cerebral tissues. Figure
2.8 (b) shows the monolithically integrated microﬂuidic channels connecting with
the sampling inlet. Two droplet detection electrodes in contact with the inner
space formed by the microchannel are shown as well. Their surface area are 80 x
80 μm2. These electrodes are meant to count the aqueous droplets separated by
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oil plugs by monitoring the change of conductivity between these 2 phases.
240 μm
86 μm
50 μm
150 μm
90 μm
20 μm (4x)
stimulation electrodes 
recording electrodes (4x) channel electrodes 
sampling inlet 
(a) (b)
microchannels
Figure 2.8 3D sketch of the atraumatic distal tip conﬁguration. (a) Main dimensions of the
probe tip. Two large stimulation electrodes (150 μm and 90 μm) as well as 4 recording
electrodes (20 μm) are included on the top layer of the probe. (b) Detail of the microﬂuidic
channel network (in orange) at the probe tip, on the same device. The sampling inlet
(50 μm) joins the main u-shape microchannel
2.3 Microfabrication
We used here a rather unconventional approach for the microfabrication of the
devices. Instead of starting with the back of the probe and ending with the probe
top layer, the opposite procedure was followed. It allowed to concentrate every
active elements on the same surface of the ﬁnal device. The active elements
include the Pt electrodes and the sampling inlet assembled on a PI base. The
main steps of the fabrication process are summarized in Figure 2.9.
As it can be observed, two silicon wafers were processed in parallel. On the
ﬁrst wafer, a 1 μm thick WTi(200 nm) - Al(800 nm) sacriﬁcial layer was sputtered.
Then, a 3 μm PI layer was spin-coated and patterned using photolithography.
Before the etching step, a process optimization step was implemented: a reﬂow
of the photoresist mask (AZ-92XX) at 115 ◦C during 2min was performed. By
transferring the pattern to the PI, this allowed to generate a conical proﬁle rather
than a vertical wall between the two levels of the metal layer (electrical tracks
and electrodes). A 350 nm sandwich Ti-Pt-Ti metal layer was then sputtered and
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(b) 2nd wafer:
wafer 2
(a) 1st wafer:
(c) Bonding:
(d) Release:SU-8
SU-8
Mylar
wafer 1
microchannel
Pt+Ti
Pi
Pi
Al
WTi 
wafer 1
Figure 2.9 Main fabrication steps of the neural probe. (a) The ﬁrst wafer includes PI, Pt
(platinum) electrodes and SU-8 (microchannels wall). (b) The second wafer includes a Mylar
ﬁlm and a SU-8 layer (microchannels cover). (c) The bonding is performed by lamination
before the ﬁnal release of the probe (d).
etched to form the electrodes and the electrical tracks. Figure 2.10 shows an
intermediate step of the microfabrication process (after metal deposition and
etching) focusing on the probe tip region. We notice the circular electrodes are
situated on a lower level (3 μm under) than the electrical tracks.
Figure 2.11 (a) and (c) show speciﬁc transition areas where the change of level
occurs without process optimization (without photoresit reﬂow). The transition
between the upper and bottom level is vertical, thin and prone to damages if the
ﬁlm is bent. In contrast, ﬁgure 2.11 (b) and (d) show the same regions on another
sample on which photoresist reﬂow was performed prior to metal deposition. The
metal transition between the two levels is much smoother while the thickness of
the trace (transition section) is only slightly thinner than on a ﬂat surface.
The electrical insulation between the metal traces was obtained with a second
spin-coated PI layer patterned by photolithography. It allowed to open electrodes
included into the microﬂuidic channel as well as the sampling inlet. Finally, a
40 μm thick SU-8 photoresist layer was deposited and patterned by photolithogra-
phy. It served as a structural material forming the microchannel walls.
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100 μm
Figure 2.10 Detail of the distal region of the neural probe comprising the set of
microelectrodes at an intermediate fabrication process step. The SEM picture was taken
after the metal deposition and the electrical tracks etching. The electrode surfaces are a step
under (3 μm) the level of electrical tracks.
5 μm 5 μm
5 μm 5 μm
(a) After process optimizationInitial situation
After process optimizationInitial situation
(b)
(c) (d)
Figure 2.11 Eﬀect of photoresist reﬂow prior to PI etching and metal deposition. (a) and
(c) show regions of electrical track level change when no reﬂow was performed prior to metal
deposition. In comparison, (b) and (d) show the same regions on diﬀerent devices where a
reﬂow was performed. The metal transition from the two levels is much smoother in this
case.
A 50 μm Mylar ﬁlm was laminated on the second wafer. A droplet of water was
applied between the wafer and the Mylar foil to enhance the bonding (Steigert
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et al. 2008). Then, a 40 μm thick SU-8 layer was spin-coated over the ﬁlm and soft-
baked. After this step, the Mylar ﬁlm with the SU-8 layer on the top was peeled
off the second wafer. Then, the Mylar and SU-8 structure were ﬂipped bottom-up
and assembled on the top of the ﬁrst wafer. The bonding between the SU-8 layers
was obtained by lamination applying heat (60 ◦C) and a compression force (36 kg,
between the rolls). A ﬁnal photolithographic step (exposition through the Mylar
ﬁlm) allowed to reinforce the bonding.
The release of the probes was performed by anodic dissolution of the sacriﬁcial
layer according to the method proposed by Metz et al. (Metz, Jiguet, et al. 2004).
After the release, the devices were dipped in a 10:1 HF-DI water solution for 10 s
to remove the Ti layer above the Pt layer.
The previously described process was optimized over 5 fabrication batches. The
most challenging step consisted in the bonding between the top and bottom layers
of SU-8. The roller lamination as well as the exposition through the Mylar ﬁlm
allowed to improve drastically the reliability and brought the production yield
from 15% to 85 % after implementation (each wafer includes 32 neural probes).
2.4 Neural Probe - Features
A neural probe including microﬂuidic channels, recording and stimulation elec-
trodes was successfully fabricated. A microscale T-junction droplets generator has
been included in the tip of the probe. This enables the collection and the direct
segmentation of the extracted ﬂuid. The proximal area of the probe includes two
legs which constitute the input and output of the microﬂuidic channels. On the
same region, the electrical contacts (2mm×2mm) allow to make the connection
with the electrodes of the distal tip. Two microﬂuidic channels of rectangular
section (40 μm×80 μm) cross the structure from the legs to the tip of the probe.
They join at the distal tip where they form a T-junction with a third microchannel
connected to the sampling inlet (D = 80 μm). Close to the sampling inlet, two
stimulation electrodes with a diameter of 150 μm (distal) and 100 μm (proximal)
are distributed longitudinally. The proximal stimulation electrode is smaller in
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order to provide sufﬁcient room for the electrical tracks (10 μm) passing nearby.
Four recording electrodes with a diameter of 20 μm are distributed in a tetrode-
like conﬁguration. This permits to discriminate signals from individual neurons
when recording. Square electrodes (80 μm×80 μm) are integrated inside the
channel, facing down. Each of these elements is presented in ﬁgure 2.12. The
white dashed-line highlights the path of the microﬂuidic channels. A zoom on the
distal tip shows the electrodes.
Proximal side
Distal tip
Contacts (8x)Fluidic inputs and outputs
Microfluidic 
channels (2x)
Droplets detection 
electrodes
Stimulation 
electrodes
(Ø=100, 150 μm)
Recording 
electrodes 
(Ø=20 μm, 4x)
2
4
0
 μ
m
 
5 mm 
Figure 2.12 Polyimide and SU-8 based neural probe after microfabrication. The device
includes stimulation and recording Pt (platinum) electrodes as well as 2 microﬂuidics
channels joining at the distal tip to form a T-junction (droplets generator). The
white-dashed line represents the microchannels pathway.
On the left of ﬁgure 2.13 is presented a cross section view of the probe tip
performed with a scanning electron microscope (SEM, LEO 1550). The openings
of the two microchannels as well as the 8 electrical tracks assembled on the top
of the structure are well distinguishable. We observe that a slight misalignment
occurred between the SU-8 cover and the rest of the structure during the bonding.
On the right of ﬁgure 2.13, a SEM picture shows the two stimulating electrodes
as well as the 4 recording electrodes. The sampling inlet at the middle of the
tetrode electrodes can be observed as well (white arrow).
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20 μm 100 μm 
(a) (b)
Figure 2.13 (a) SEM picture of the probe tip after a cross-section cut. The microchannels
are open, and, on the top of them, we observe the 8 electrical tracks. (b) The stimulation
and recording electrodes as well as the sampling inlet (white arrow) are integrated on the
same surface, in close proximity to each other.
2.5 Neural Probe - Microﬂuidic Model
The probe microﬂuidic network is composed of 3 entries which connect in a
T-junction as represented in ﬁgure 2.14. Figure 2.14 (a) details the distal tip
of the neural probe where the droplet generation occurs by controlling the
Perﬂuoromethyldecalin (PFD) input Qin and output Qout ﬂows. Qsampled is the
resulting inﬂow of the aqueous phase external to the probe. Figure 2.14 (b) is an
equivalent ﬂuidic T-junction model of this system.
Q
in
Q
out
Q
sampled
Q
in
Q
out
Q
sampled
equivalent model
(a) (b)
PFDPFD
Figure 2.14 (a) Microﬂuidic network at the distal tip of the neural probe. This 3 entries
system is composed of the ﬂows Qin, Qout and Qsampled. In this system, the white phase is
the PFD whereas the aqueous phase is orange. (b) T-junction analogy modelling the probe
tip microﬂuidic system.
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At the junction of the channels, the mass conservation condition requires the sum
of ﬂows equal zero:
∑
i
Qi = 0 (2.15)
This relation, together with equation 2.3, are similar to the fundamental laws of
electricity. Indeed the linear pressure-ﬂow relationship is analogous to Ohm’s law
U =R ·I binding the current I to the potential differenceU . The mass conservation
is reminiscent of Kirschhoff’s law
∑
I = 0 at electrical nodes of circuits. It is
therefore interesting to establish a link between the ﬁelds of electronics and
microﬂuidics; the electrical current, the potential and the electrical resistance
becoming the ﬂow, the pressure and the ﬂuidic resistance, respectively. This
is of interest for modeling the behaviour of microﬂuidics. Figure 2.15 is a
ﬂuidic equivalent model of the probe showed in ﬁgure 2.7. In this model the
intersection T represents the junction at which the microchannels connect, where
the T-junction droplet formation occurs. PT is deﬁned as the pressure at this
intersection, Pext is the external pressure at the probe distal tip, near to the
sampling inlet, Pin is the pressure applied at the proximal inlet and Pout is the
pressure applied at the proximal outlet. R1 is the channel ﬂuidic resistance from
the proximal entries to the point T which is equivalent in both the upper and
bottom channel by symmetry. R2 is the ﬂuidic resistance from the distal tip
sampling inlet to the point T. Qin, Qout and Qsampled are the resulting ﬂow from
the pressure difference between the point T and the microchannel inlet, outlet
and the sampling inlet, respectively. We make here the hypothesis the channel
walls are rigid and the ﬂuid is incompressible; we therefore didn’t consider any
capacitance in this model. By the mass conservation law we can write:
Qsampled+Qin =Qout (2.16)
which, as established earlier (2.3) when introducing the pressure driven Poiseuille
ﬂow, can be further expressed:
Pext −PT
R2
+ Pin −PT
R1
= PT −Pout
R1
(2.17)
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Figure 2.15 Probe microﬂuidic equivalent model. In this system PT, Pext, Pin and Pout are
the pressures, R1 and R2 are the ﬂuidic resistances whereas Qin, Qout and Qsampled are the
ﬂows while T is the microchannels intersection.
This equation can be solved for PT and, consecutively, the ﬂows are expressed by:
Qsampled =
Pext
R2
− R1Pext +R2(Pin +Pout )
2R22 +R1R2
(2.18)
Qin = Pin
R1
− R1Pext +R2(Pin +Pout )
R21 +2R1R2
(2.19)
Qout = R1Pext +R2(Pin +Pout )
R21 +2R1R2
− Pout
R1
(2.20)
Figure 2.16 (a) shows the linear relationship between the collected ﬂow Qsampled
and a pressure difference ΔP applied between Pin and Pout, Pin being ﬁxed at
an arbitrary value of + 10mbar relative to a pressure reference Pref. Pext equals
Pref, the local pressure, ﬁxed at 1013.25mbar (standard pressure at mean sea
level) whereas the microchannel width (w) and height (h) accounts for 80 μm
and 40 μm, respectively. One may note the external ﬂuid can be collected only
when ΔP > 10mbar, as expected.
The impact of a pressure variation occurring in the implanted medium on the
sampling process may also be evaluated with this model. Figure 2.16 (b) displays
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the Qsampled variation function of a Pext for constant condition at the probe entries;
Pin = Pref + 10mbar and Pout = Pref - 40mbar (meaning Δ P = 50mbar) where
Pref still equals 1013.25mbar. We can extract from this graph the sensitivity to
an external change of pressure S = 0.20 nLs−1mbar−1 which is rather large. In in
vivo conditions, Pref should remain constant and should not disturb the sampling
process though. The intracranial pressure in humans is slightly higher than the
local pressure and remains stable over time; standard values range between +
9.3 to + 20 mbar (= + 7 to + 15 mmHg) (Czosnyka et al. 2004; Chapman et al.
1990).
The third plot in ﬁgure 2.16 (c) assesses the impact of the ﬂuidic resistance
R2 increase which may be a situation occurring if tissues gets inside the probe
and clog the sampling inlet. The system conditions have been ﬁxed to Pin =
Pref + 10mbar and Pout = Pref - 40mbar , Pref = Pext = 1013.25mbar and the
microchannel width-to-height ratio to wh = 2. Interestingly we observe the system
is relatively resilient against clogging; Qsampled starts dropping signiﬁcantly only
when the channel section reaches a half of the initial area A0 (A0 = 40 μm x
80 μm).
In the precedent description, we did not take into account that the upper mi-
crochannel was a biphasic droplet segmented ﬂow. The modeling of a two-phase
ﬂow is substantially more complex than a single-phase ﬂow. Indeed, new ele-
ments must be included in the description such as the contribution of interfaces
between the two phases as well as the capillary effects with the microchannel
walls. Let’s consider such a situation where a carrier ﬂuid, the PFD imiscible
phase, transports the aqueous droplet collected from the tissues. We also make
here the reasonable hypothesis the droplet radius is larger than the channel
length scale, which means the droplet occupies most of the channel cross section
and is therefore ﬂattened in the channel. A non-trivial description of the total
pressure drop along the channel can be written (Bretherton 1961; Wong et al.
1995; Fuerstman et al. 2007):
ΔP =ΔPPFD +ΔPdrop +ΔPcaps (2.21)
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Figure 2.16 Model-based prediction of the neural probe microﬂuidic behaviour with
diﬀerent parameter variations. The model parameters ﬁxed for each plot are given in the
legend of each graph. All model pressure entries are relative to a reference pressure Pref =
1013.25mbar. (a) Qsampled dependence over ΔP, a pressure diﬀerence applied between Pin
and Pout, Pin being ﬁxed to a pressure of Pref + 10mbar. (b) Qsampled plot function of the
local variation of Pext. (c) Qsampled resilience over the increase of the ﬂuidic resistance R2
consecutive to a cross section change. A0 is the initial area of the cross section where the
width (w) to height (h) ratio is maintained constant; w/h= 2.
where we distinguish three contributing terms ΔPPFD the pressure drop in the
carrier ﬂuid, ΔPdrop the pressure drop in the aqueous droplet and ΔPcaps the
pressure drop at the front and rear ends, or caps, of each droplet.
The formulation for Δ Pcaps was ﬁrst proposed by Bertherton for a circular cross
section channel and adapted to a rectangular cross section by Wong et al. (Brether-
ton 1961; Wong et al. 1995). The pressure contribution of the droplets caps is the
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consequence of the asymmetrical deformation of the front interface (ﬂattening)
compared to the rear (elongating) due to the droplet displacement in the carrier
ﬂuid (Bretherton 1961). Figure 2.17 provides a qualitative plot of the pressure
drop contributing terms in such a ﬂow for viscous droplets (in our condition,
λ= μdropμPFD =
8.9e−4(Pa s)
6.4e−3(Pa s) = 0.14⇒ λ∼ 1) (adapted from Baroud et al. 2010).
P
ΔP
PFD
ΔP
drop
ΔP
drop
ΔP
PFD ΔPPFD
λ ~1
Flow direction
ΔP
caps-rear
ΔP
caps-front
ΔP
caps-rear
ΔP
caps-front
Figure 2.17 Qualitative plot of the pressure variation along a microchannel ﬁlled with
viscous droplets carried by an imiscible PFD phase. λ= μdropμPFD . (adapted from Baroud et al.
2010)
The equation 2.21 can be written:
ΔP =Rh ·QPFD +Rh ·Qdrop +n · clambda
γ
H
Ca2/3d (2.22)
where Rh is the ﬂuidic resistance, Cad =
μU
γ
the dimensionless capillary number (U
= the ﬂuid velocity, γ = the surface tension), clambda a dimensionless parameter
that depends on λ and on the geometry3 and n the number of droplets. We
distinguish the two linear contributions from the ﬂuid inside the droplets and
from the outside ( = PFD carrier ﬂuid). The only non linear term comes from
the droplets caps contribution at the interface PFD/droplet whose pressure jumps
scales as Ca(2/3)d and takes discreet values as it depends on the number of droplets
n in the upper channel. We can quantitatively compare the contribution of the
term Δ Pcaps to the other pressure drop contributions. For instance, for a ﬂow of
viscous water droplets (λ = 0.00089 Pas) transported at a velocity of 3mms−1 in
3explicited in (Wong et al. 1995)
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a carrier ﬂuid of viscosity λ = 0.0064 Pas ﬂowing through a rectangular channel
of width W= 80 μm and height of 40 μm with an interfacial tension between
the PFD and the water of γ = 3.5×10−2 Nm−1 (Peters et al. 2013), we ﬁnd
ΔPcaps = 0.0992mbar per droplet which is not negligible since up to 75 droplets
(droplet length of 300 nL considered) can ﬁll the channel during sampling. It
could therefore be interesting to extend the precedent single phase ﬂow model
to a biphasic ﬂow model in order to predict the behavior of the neural probe
microﬂuidic system more accurately. In the scope of this thesis though, we will
limit our description to the single phase ﬂow model which gives a good ﬁrst
approximation of the neural probe microﬂuidic network behavior.
2.6 Conclusions
In this chapter we went through the theoretical basics useful for the design and de-
velopment of micro-scale devices which include electrical and ﬂuidic components.
The main requirements for the development of the neural probe were deﬁned.
Among these requirements the biocompatibility remained one of the major point.
In order to minimize the impact of the device in vivo, microfabrication methods
were employed and allowed to reduce the dimensions of the probe and integrate
the following elements in close proximity to each other:
• A droplet generation mechanism connected to a monolithically integrated
microﬂuidic channels
• Microelectrodes for stimulation and recording
The microfabrication process proposed enabled to produce the devices with a
yield reaching 85 %. A ﬂuidic model of the probe enabling the prediction of the
behavior of the system under deﬁned conditions was proposed as well. The next
chapter will address the testing of the probe functional testing prior to performing
in vivo experimentation.
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Neural Probe - Functional Validation
3.1 Introduction
In this chapter is addressed the functional validation of the neural probe main
functions. Characterization tests are performed regarding the device mechanical,
electrical and ﬂuidic properties. In particular, the mechanical probe strength is
assessed and its ability to be inserted in the neural tissues tested. The electro-
chemical behavior of the probe microelectrodes is assessed as well. Finally, the
droplet collection mechanism is evaluated for the monitoring of a rapid molecular
change occurring in a controlled medium, as it can be the case in the neural
tissues. It is worth mentioning that this chapter is partly inspired from a scientiﬁc
article recently published by the author (Petit-Pierre et al. 2016).
3.2 Mechanical Characterization
3.2.1 Penetration Test
Traditionally, neural interfaces have been constructed with little regards to their
mechanical properties. For instance, silicon-based neural recording systems
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have been widely used and function as good electrical interfaces. But their
material stiffness creates an important mismatch with the viscous neural tissues
environment (B. Lee et al. 2005). According to the requirements deﬁned at the
beginning of chapter 2 (table 2.1) the neural probe mechanical strength must be
sufﬁcient to ensure its integrity during surgical handling and device operation.
Microfabrication yield after process optimization has been showed to be relatively
high (85 %) which ensures a good device ﬁnish and mechanical integrity. Apart
from manipulation, the neural probe must remain stiff during penetration in the
brain tissues which represents one of the major mechanical stress the shank is
subjected to. Due to the device small dimensions and the low materials Young’s
modulus (ESU-8 = 2.0 GPa), the neural probe is ﬂexible as it is shown in ﬁgure
3.1. It can be bent without structural damage at a radius of roughly 6.5mm.
As introduced in chapter 1 ﬂexible polymer materials are advantageous since
they are better accepted in the brain tissues than rigid silicon-based neural probe
(Rousche et al. 2001; Mercanzini, Colin, et al. 2009). In particular they are
less prone to tissues damage following micro-motion occurring between the
brain and the probe (B. Lee et al. 2005). However this property does not serve
the implantation process as the probe structural stiffness must be high enough
not to brake or buckle during penetration in the tissues. In order to assess the
R = 6.5 mm
R
Figure 3.1 Neural probe ﬂexibility during a qualitative bending test. The probe can be bent
at a radius of r = 6.5mm without any impact on its mechanical integrity.
probe ability to enter the brain tissues, penetration tests were performed in brain
phantoms. Brain phantoms act as mechanically equivalent media simulating
cerebral tissues mechanical properties. Two different phantoms were prepared; a
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2.2 % agarose gel and a gelatine solution prepared from commercially available
product (gelatine sheet). Figure 3.2 (a) shows an equivalent model of the
experiment in which a vertical displacement of magnitude d (oriented towards
the z axis) is applied to the probe and the resulting Fph, the reaction force of
the brain phantom is monitored. The experimental setup consisted in a z-axis
linear stage (vertical motion), two brain phantoms prepared in transparent cups,
a neural probe and a precision lab scale (Ohaus Pionner 210GX). The neural
probe mounted on the linear stage (not visible) after insertion in the brain
phantom placed on the lab scale is showed in ﬁgure 3.2 (b). The reaction force
F
ph
Brain 
phatom
d
Neural probe
z
(a) (b)
brain 
phantom
neural 
probe
lab scale
vertical 
stage
Figure 3.2 (a) Model of the penetration test performed. The neural probe is vertically
displaced along the z axis until penetration in the brain phantom over a distance d. The
maximum force reached along the course of displacement is recorded. (b) Experimental
setup. Brain phantom were prepared and placed in transparent cup over a lab scale. The
neural probe was mounted on a z-axis stage (vertical displacement) and implanted in the
brain phantom until a penetration depth of 8 mm was reached while recording the force
Fph exerted by the medium over the probe was recorded along a translation of
d = 8mm performed at a velocity of roughly 1mms−1. Each experiment was
repeated 3 times on the two brain phantoms. Maximum force during insertion
in the agarose gel reached 6.21 ± 0.48mN while in the gelatine it reached 3.50 ±
0.98mN. In every experiment the neural probe remained vertical and didn’t show
any buckling behaviour. A recent study about the mechanical properties of mouse
brain during penetration of neural probe reported a maximum force reached
upon shank insertion in the cortex to be in the range of 2.5mN (probe diameter d
=200 μm, insertion speed 0.8mms−1) (Sharp et al. 2009). As indicated in ﬁgure
3.3, the results obtained with our experiment are both of higher magnitude than
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this value obtained in vivo. In particular, the probe was submitted to a force twice
larger when tested against penetration in the 2.2 % agar gel (brain phantom 1).
As a result, it is expected the probe insertion in the rodent brain should not cause
any issue.
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Figure 3.3 Maximum force reached during penetration tests in brain phantom 1 (agarose
gel 2.2 %) and 2 (gelatine). The results obtained are compared to the in vivo maximum
insertion force reported for mouse brain cortex penetration with a probe of similar geometry.
In both phantoms, the neural probes withstand the test perfectly, the probe trajectory
remained vertical and no buckling occurred.
3.3 Electrical Characterization
3.3.1 Impedance Spectroscopy
In a ﬁrst approach, the electrochemical behaviour of the electrode/electrolyte in-
terface was examined using impedance spectroscopy compared with a silver/silver-
chloride reference electrode (Ag/AgCl). The measurements were conducted using
a commercially available impedance analysis system (Agilent 4294A, Agilent tech-
nologies). Impedance modulus and phase were recorded at discrete frequencies in
the 100Hz to 5MHz range. The probe and the counter electrode were immersed
in a saline solution (0.9% NaCl pH 7.0, ρ = 16mScm−1) and the impedance
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spectroscopy performed at an oscillation amplitude of 50mV.
The electrode-electrolyte behaviour was approximated by an equivalent circuit
including a resistive and capacitive element as introduced in chapter 2.1.3 (Mer-
canzini, Colin, et al. 2009; Altuna, Menendez de la Prida, et al. 2012). Figure 3.4
(a) introduces the equivalent electrical circuit of this situation. The interfacial
capacitance is here approximated by a constant phase element (CPE) which best
describes the double layer behaviour at the interface with the solution. We also
considered a charge transfer resistance (RCT), an element which models the
resistance to the charge transfer process taking place at the electrode surface. The
CPE and the RCT assembled in parallel are combined in series with a spreading re-
sistance (Rs) and a bulk resistance (Rbulk ) as shown in ﬁgure 3.4 (a). Finally, the
probe dielectric insulation is modeled by a capacitance (Cdielectric) in parallel to
these previous elements. Figure 3.4 (b) and (c) show a typical impedance/phase
spectrum for the recording electrode (D = 20 μm) and the stimulation electrode
(D = 150 μm), respectively. The spectra obtained are in accordance with simi-
lar devices previously characterized with the same method (Merrill et al. 2005;
Mercanzini, Cheung, et al. 2007; Béduer et al. 2015). Using the Peak Resistance
Frequency method (PRF), we observe a difference of one order of magnitude
between the spreading resistance of the 20 μm electrode (Rs = 2.0×104Ω) and
the 150 μm (Rs = 3.1×103Ω) when the phase is closest to zero (Mercanzini, Colin,
et al. 2009). This gap is explained by the difference in size of the electrode (20 μm
vs. 150 μm), the spreading resistance being inversely proportional to the diameter
of the circular electrode (Newman 1966). Additionally, the electrical resistance
of each track was measured with a 4 points probe station (SüssMicrotec, PM8).
The measurements were performed track by track, between the proximal contact
and the corresponding electrode at the distal tip (see ﬁgure 2.12). Contacting
the electrodes integrated in the microﬂuidic channels required the delamination
of the bottom SU-8 layer in order to access the conductive metal layer. Each
electrode was successfully connected and the track electrical resistance ranged
from 652Ω to 781Ω (longer tracks are slightly more resistive). Compared to the
values found for Rs using the PRF method, the contribution of the tracks electrical
resistance will only slightly affect the system since the values are at least 4 times
smaller.
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Figure 3.4 (a) Equivalent electrical model for an electrode-electrolyte interface. (b)
Impedance magnitude and phase for a 20 μm recording electrode (c) and a 150 μm
stimulation electrode.
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3.4 Fluidic Characterization
3.4.1 Droplet Generation - Demonstration
The T-junction included at the distal tip of the probe acts as a droplet generation
system and is a crucial element of the technology developed in this work. The
droplet generation process is controlled by modulating the ﬂow of the PFD carrier
phase which circulates in the microchannels of the probe. The PFD is injected
in the proximal ﬂuidic inlet, circulates toward the distal tip and returns to be
re-collected in the proximal ﬂuidic outlet. In order to connect the probe with
the ﬂuidic driving control, fused silica capillaries (ID = 250 μm, OD = 360 μm)
were bonded to the probe legs. The capillary were chosen large enough to be
introduced over the probe legs. They were assembled with epoxy glue according
to ﬁgure 3.5 in order to ensure a liquid-tight and pressure-resistant connection.
Each capillary (length = 40 cm) is connected to a pressure-driven reservoir ﬁlled
glass capillaryprobe leg
Epoxy adhesive
(a) (b)
ID = 250 μm200 μm
Figure 3.5 Drawing of the solution implemented to ensure a watertight connection between
the neural probe proximal inlet/outlet (probe leg) and the fused silica capillaries. (a) The
capillary is big enough to be inserted over the probe leg. (b) Tight bonding is performed
using epoxy adhesive.
with PFD and controlled by a pressure driving unit (Fluigent, module MFCS-MZ).
This system enables to apply a positive or negative pressure at the probe proximal
inlet/outlet with respect to the ambient pressure. As introduced in chapter 2.5,
the ﬂuidic behaviour of the probe can be modelled by a 3 entries system linked
by the T-junction (included in the probe distal tip). Qin and Qout are the ﬂow
resulting from the pressure applied on each microchannel of the probe. Qsampled
is the extracted ﬂow from the sampling inlet. A droplet generation triggered by
the actuation of Pin and Pout is possible when the following conditions are met
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(see equation 2.16 in chapter 2.5):
Pin > Pext > Pout (3.1)
where Pext is the pressure at the probe distal sampling inlet. Figure 3.7 shows
a sequence in which a droplet is generated. In order to obtain this result a
dedicated setup was designed allowing to collect clear water in the PFD carrier
phase while focusing on the probe distal tip with a camera (IDS, uEye UI-1240SE)
as represented on ﬁgure 3.6. The top layer of the neural probe is made out of
a 6 μm thick PI substrate providing a direct optical access to the microchannels.
Figure 3.7 demonstrates the generation of a water droplet included in the PFD
carrier ﬂuid. At t = 0 s, the droplet is in preparation and still attached to the
sampling inlet, at t = 0.126 s the droplet detaches and then propagates along the
channel. At the end of the sequence we notice that the next droplet is already in
preparation. For this demonstration, a constant pressure difference between Pout
and Pin of Δ P = 50mbar was applied. This enabled to generate droplets of 0.62 nL
at a frequency of 0.13Hz. Higher frequencies can be obtained by increasing ΔP.
3.4.2 High Frequency Droplet Sampling
In the last experiment it was demonstrated how the droplet collection process
occurs in standard conditions. In this section we demonstrate the probe ability to
capture a rapid molecular composition change with its high frequency droplet
sampling mechanism.
3.4.2.1 Experimental Setup.
In this experiment, two syringes ﬁlled with blue-colored water and clear water are
both connected to the same tube, called in the following the shared tube (Saint-
Gobain, Tygon, ID=0.51mm, OD=1.52mm). They are operated independently
by 2 syringe-pumps (Cetoni, Nemesys) and are employed in order to generate an
optically detectable molecular composition change in the shared tube. A neural
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Figure 3.6 Experimental setup for the testing of the droplet generation process. The neural
probe is actuated by two pressure driving units which generate a ﬂuid motion through the
capillaries and towards the probe microchannels. With this setup, water droplets separated
by PFD phase are generated while the process is recorded with an optical camera.
probe is inserted in the same tube. It is operated by two pressure-pumps, as
in the precedent setup, and actuated in order to continuously collect droplets
of the water circulating in the shared tube. A ﬁrst measurement of the mean
light intensity through the tube, before the sampling spot, is performed with a
photodiode (Vishay, model BPW34) and an ampliﬁer (Stanford Research System,
SR570). A second measurement of the mean light intensity, focused on the
passing droplet on the microchannel of the probe, is performed with a microscope
(Zeiss, Axiowert S100 TV). The signal is recorded using a camera (IDS, uEye
UI-3600CP) and the mean light intensity of images computed using the software
ImageJ. A representation of this experimental setup can be seen in ﬁgure 3.8 (a).
61
Chapter 3. Neural Probe - Functional Validation
t = 0 t = 0.126 s t = 0.140 s t = 0.154 s
Figure 3.7 Sequence of a water droplet generated in a PFD carrier phase occurring at the
T-junction. At t=0, the droplet (volume = 0.62 nL) is in preparation. The droplet detaches
(t=0.126 s) and propagates along the microchannel (from t=0.140 s to t=0.154 s). The red
crosses underline the beginning and the end of the droplet.
3.4.2.2 Experimental Conditions
A fast transition from clear water to blue water was generated in the tube. In
order to obtain this effect, the tube was ﬁrst ﬁlled with clear water and ﬂushed
during 5 s at a ﬂow rate of 10 μLs−1 using the syringe pumps. Then, the clear
water syringe pump was switched off. The droplet sampling process was started
by modulating the pressure applied to the PFD circuit connected to the probe.
A pressure of Pin = 50mbar and Pout = −400mbar was applied (relatively to
the local pressure). Then, the ﬂow of blue dyed water from the second syringe
pump was turned on at a value of 10 μLs−1. This resulted in the generation of
a fast color change in the tube recorded both before the sampling spot (A), via
the photodiode, and after the sampling spot (B) with a camera focused on the
droplets passing in the probe, as illustrated in ﬁgure 3.8 (b). When the mean
light intensity measurement was stabilized in both spots (A and B) the recording
was stopped.
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Figure 3.8 (a) Representation of the setup designed in order to validate the eﬀectiveness of
the droplet sampling mechanism. (b) Mean intensity measured at position A, before the
sampling spot and at position B, on the passing droplets. Strong temporal correlation
between both measurements is demonstrated.
3.4.2.3 Results
Under these conditions, fast color changes were generated and captured within
the sampling system of the probe. In the bottom of ﬁgure 3.8, the concentration
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change measured at the location A (dashed line) and B (continuous line) is shown.
On measurement A (located before the sampling spot) we can note a fast decrease
of intensity starting at time t = 1 s that stabilizes after 2.5 s. The major part of
this transition occurs in 1.5 s. On measurement B, the light intensity through the
probe microchannel is presented. Each peak corresponds to a passing droplet
thus demonstrating a fast collection frequency of 6Hz. Under these conditions,
the mean volume of a droplet was 0.84 nL. The level at which the signal returns
after every droplet passes corresponds to the signal intensity of the PFD phase. A
strong correlation regarding the time at which the change occurs and the shape
of the curves is demonstrated on measurement A and B. This suggests that the
droplet sampling mechanism included in the neural probe is able to thoroughly
capture a rapid change of concentration occurring in the external liquid ﬂowing
in the shared tube.
3.5 Discussion
Achieving high temporal resolution during in vivo sampling in brain tissues
is a challenge since neurotransmitters release typically occurs in the range of
the second (Venton et al. 2006; Rossel et al. 2003). The maximum achieved
sampling rate of this device was 6Hz (meaning a droplet every 170ms). It
indicates we should be able to capture in real time a concentration change of a
neurotransmitter occurring in the brain with this tool. One of the main limitation
to this approach relates to the maximum volume of interstitial liquid we can
remove from the tissue without causing any damage. Since the volume of each
droplet is 0.84 nL, it represents, at a frequency of 6 Hz, a removal of an equivalent
constant ﬂow reaching 302 nLmin−1. The impact of direct sampling in the neural
tissue was demonstrated to be minimized when the ﬂow rate was kept under
50 nLmin−1 and the total volume removed under 2.5 μL (Kennedy et al. 2002).
Our approach could deplete quickly the medium since the probe ﬂow rate is 6
times higher than 50 nLmin−1. However, the effect of depletion can be strongly
limited by performing the sampling during short periods of time typically during
1 minute or less which would be fully compatible with our approach. In this
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situation and with the parameters cited above (302 nLmin−1 during 1min), the
total volume removed is 302 nL which seems acceptable. We can even imagine
to generate single droplets "on-demand" with fast burst of pressure. Another
approach for limiting the depletion would be to replace the liquid removed by an
equivalent volume of physiological solution injected at the same spot. It could
easily be implemented by adding a microﬂuidic channel on the probe dedicated
to this function.
Regarding the time resolution, there are good chances to further increase the
sampling rate by driving the system at a superior difference of pressure between
the entries. This will result in the reduction of the space between droplets (PFD
segment volume) and the increase of the droplets volume as supported by Gupta
et al.(Gupta et al. 2009). Increasing the volume of the droplets is a beneﬁt
regarding the analysis of the samples. A limitation can however be related to
the actuation system which must be fast and compatible with high pressure
controls. Admitting that such equipment is available, special care will be needed
to reinforce the ﬂuidic connections within the neural probe. In preliminary tests,
the neural probe was connected to syringe pumps that could operate the system
at high ﬂow rate. In this conﬁguration, ﬂuidic connection failures were observed
when the ﬂow rate reached a value above 1 μL/sec, meaning a pressure in the
range of 1.5 bar (with our geometry).
Now that the sampling process has been proven to be functional, one may deﬁne
an analysis method compatible with the sample conﬁgurations (droplet train).
Most detection methods require a minimal sample volume and are characterized
by a maximum achievable sensitivity (Kennedy 2013). High-Pressure Liquid
Chromatography (HPLC) coupled to electrochemical or ﬂuorescence detection
would have been good candidates but are incompatible with the current volume
of the droplets (V = 0.84 nL). It is too small compared to the typical 10 μL to 20 μL
injected sample volumes (Zapata et al. 2009). Electrospray Ionisation (ESI)-MS
has also been proposed as a compatible method for analyzing samples segmented
in droplets (T. R. Slaney et al. 2011). However this method would require
the addition of a reagent of identical volume in each droplet before analysis
which is certainly very challenging to control. Another method achieving high
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sensitivity with low sample volume (pL to nL) is Capillary Electrophoresis (CE)
combined with Laser Induced Fluorescence (LIF). This would require further
developments in order to sort and manipulate the droplets of interest while
still controlling their sequence. Droplet segmentation guarantees the temporal
resolution of the measurement. However, a limit to this approach is that it renders
difﬁcult the interface with existing analysis methods. Indeed, during the analysis,
droplets cross-contamination must be avoided whereas droplets order must be
maintained to keep a consistent sampling time-history. The PFD phase may also
clog the analytic equipment quickly (such as a HPLC column). The solution to
this challenge will certainly consist in associating to the analysis a speciﬁc and
tailor-made sample preparation platform compatible both with the droplet train
and the detection equipment.
3.6 Conclusions
In this chapter were assessed the main functions of the neural probe with regards
to the future in vivo application of the technology. The device combines, in
one single tip, recording and stimulation electrodes with a micro-scale droplet
generator. In particular, the mechanical property of the probe and its ability to be
implanted in the brain tissues was assessed. The tests performed showed that:
• The probe stiffness is high enough and withstand almost twice the compres-
sion stress reached during insertion in mouse cerebral cortex
The electrochemical behaviour of the microelectrodes was tested in a saline
solution (0.9% NaCl pH 7.0). The impedance spectra recorded showed that:
• The electrode-electrolite interaction behaviour is similar to equivalent device
proposed in the literature
• The stimulation electrodes will affect a larger tissue volume than the record-
ing electrodes.
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The probe’s ﬂuidic functions were assessed as well. The probe has been proven
to efﬁciently reconstitutes a rapid (1.5ms) molecular change occurring in a
controlled medium in which droplet collection was continuously performed:
• The sampling temporal resolution reached a frequency of 6Hz (one droplet
every 170ms) which is compatible with the time-range of fast synaptic
signal exchanges.
The neural probe efﬁciently answers the requirements regarding mechanical
integrity, electrical and ﬂuidic performances while providing high spatial and
temporal resolution.
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Chapter 4
In Vivo Neurochemical Sampling
In this chapter is addressed the ﬁrst in vivo testing of the neural probe and an
associated analysis method. The probe has been implanted in rat brains as part
of a pilot animal study in order to demonstrate the validity of the proposed
approach in real conditions. In parallel, a dedicated surface-based MS detection
method providing an efﬁcient way of analyzing the collected samples organized
in a droplet-train was developed and tested. The results of the in vivo trial as well
as the results of the detection are reported. It is worth mentioning this chapter
content is inspired from a scientiﬁc article recently submitted for publication by
the author of this manuscript.
4.1 Introduction - Droplet Detection Methods
The neural probe allows to collect with high resolution (under the second)
droplets separated by an oil phase. This method allows to maintain the temporal
resolution as deﬁned by the lapse of time between the generation of two droplets.
When applied to brain micro-sampling, the main challenge of this approach
remains the analysis of the samples conﬁned in low-volume, low-concentrated
and non-puriﬁed samples surrounded by non-aqueous carrier phase. As the neural
probe functions has been thoroughly discussed in the precedent chapters, this
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introduction addresses in details the droplet detection methods. Droplet analytical
platforms are an important element which contributed to the development of the
ﬁeld of droplet microﬂuidics. A large number of techniques for droplet contents
analysis have been proposed (Gu et al. 2014). Here we will concentrate on the
most promising ones with respect to our application.
Fluorescence detection is an optical method based on the analysis of the light
emission of an atom or molecule which previously absorbed light or an electro-
magnetic radiation. This process is consecutive to the increase of the molecule
energy state by an incoming excitation light followed by a return to a normal
energy level during which the ﬂuorescent emission occurs at a wavelength longer
than the exciting one. The method is useful for the detection and quantita-
tive measurements of analytes concentration. The application of this technique
includes ﬂuorescence monitoring of reverse transcription of Polymerase Chain
Reaction (PCR) within agarose droplets or enzyme kinetic measurements in
droplets formed out of a ﬂuorescein concentration gradient (Zhang et al. 2012;
Bui et al. 2011). A promising application of the technology was proposed in a
study about a microﬂuidic device for fast immunoassay detection based on a
ﬂuorescent detection (chip-integrated) which monitors a droplet bi-phasic ﬂow.
The device enabled highly sensitive detection (14 pmol sensistivity) of congenital
hypothyroidism (TSH hormone), a frequent occurring disease of the newborns
(1:3000 to 1:4000)(Ali-Cherif et al. 2012). The limit to ﬂuorescent detection
remains that a ﬂuorescent label must, in most cases, be bound to the molecule of
interest which may be an issue. Indeed the process of adding this label involves
complex droplet manipulation and implies that the label is existing, which is
often not the case.
Electrochemical detection has also been proposed as an effective method for
the analysis of droplets content. The technique is based on the detection of
the oxidation or reduction reaction of an analyte. The electroactive analyte is
subjected to an electrical potential while the resulting oxydation or reduction
current change is recorded with two electrodes. Thus glucose detection in
microdroplets using Pt and Ag/AgCl electrodes or graphene-cobalt oxide needles
achieving high sensitivity was demonstrated (Lindsay et al. 2007; X. Wang et al.
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2012). In droplet-segmented ﬂow conﬁguration, the setup generally employs
electrodes integrated within a ﬂuidic channel which successively contact the
droplets when they pass by. For instance, on-chip approaches with integrated
droplet electrochemical detection were proposed for enzyme kinetics and rapid
kinetics reaction detection (Han, W. Li, et al. 2009; Han, Chang, et al. 2012).
Similarly, Pt black-covered electrodes integrated in a microﬂuidic chip detector has
been used for glucose detection in human blood serum (Gu et al. 2014). Detection
of Da at ultra-low Limit of Detection (LOD) (5 pmol) was demonstrated using a
microﬂuidic chip containing a band electrode covered with carbon nanotubes for
electrochemical detection (Sansuk et al. 2013). Although the principle was shown
on a monophasic ﬂow, there are good chances to use the same method on a bi-
phasic droplet ﬂow which would certainly provide valuable information regarding
neurotransmitter content in the samples. The main issue with electrochemical
detection relates to the electrode surface cleanliness, a crucial parameter for
a stable detection, which is difﬁcult to maintain after several analysis cycles.
Another problem may arise from the difﬁculty to distinguish between two different
species with close oxidation or reduction potential contained in a same sample.
Regarding this aspect, ECF-containing sample analysis without puriﬁcation step
will most probably be very challenging as the ECF contains multiple interfering
elements.
ESI is a technique used in MS in which a high potential ﬁeld (kV range) is
generated between a liquid (sample) and the MS detector creating an aerosol
(or a spray) of charged molecules towards the detector. The method has been
proven to be compatible with droplet segmented ﬂows (S. Sun et al. 2014; Kelly
et al. 2009; Pei et al. 2009). In bi-phasic segmented ﬂows, the oil phase is not
charged and does not form a spray but is rather washed away from the conical
spray when the potential is kept under 1 kV to 1.5 kV (Q. Li et al. 2010). High
throughput, label-free screening of enzyme inhibitor was demonstrated using
droplet segmented ﬂows analyzed with ESI-MS (S. Sun et al. 2014). In another
recent study, a microﬂuidic chip incorporating a droplet ﬂow and a surface
electrode demonstrated ESI occurring from a spyhole (Gasilova et al. 2014). The
droplet MS detection took place without sample dilution or oil removal which is
particularly convenient. ESI-MS is proven to be a versatile method permitting to
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extract a lot of information from a given sample regarding its composition and
elements/molecules concentration without being disturbed by the oil phase of a
bi-phasic ﬂow. However, the ESI approach suffers from a low tolerance to salts as
they tend to strongly cover the signals of other molecule of interest contained in
the sample. This can be an issue for the analysis of brain ECF-extracted samples
which contains a high quantity of biological salts.
Surface sample-based MS are powerful methods characterized by a high sensi-
tivity to solid samples and limited preparation steps. The conﬁguration of the
reading zone (sample target) is often associated with an xy-stage which makes
it compatible with various samples conﬁguration including a set of droplets
distributed at known position. ICP-MS is well known for the quantiﬁcation of ele-
ments in biological samples at the trace and ultratrace level (< 1 ppm) (J Sabine
Becker, Zoriy, et al. 2010). The combination of a laser ablation (LA) system
with ICP-MS provides a spatial dimension to the analysis. It has been recently
used to determine the elements distribution (mapping or imaging) in thin tissue
sections of brain (20 μm to 30 μm thick) which contributed to the understanding
of the biological processes involved in this region (J. Sabine Becker et al. 2007;
J Sabine Becker, Matusch, et al. 2010; Sabine Becker 2013; B. Paul et al. 2015).
In particular, neurological studies focusing on monitoring the changes in concen-
tration of Mn, Fe, Cu and Zn occurring in Parkinson’s diseased (PD) rats were
recently performed (Hare et al. 2009; Matusch et al. 2010; Sussulini et al. 2012).
However, the analysis based on thin-tissue brain sections require the sacriﬁce of
the animal and only reﬂects the elements image of a tissue at a given point in
time, which restricts the analysis to rather static observations.
It is believed that adapting surface-based MS detection such as ICP on droplet-
collected brain-ﬂuid samples could give rise to a reliable approach to recover
biological events and analyze their accompanying neurochemistry. The droplet
collection system gives access to a new dimension, the time evolution of the
neurochemicals captured at a precise location in the brain. The droplets, stored
in a capillary, constitute a spatio-temporal pattern reﬂecting the extracted liquid
composition overtime. In order to perform the detection we propose a speciﬁc
parylene base plate (a target reader) on which the droplet samples can be easily
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distributed and isolated at known positions. This parylene base plate will play
the role of interface between a speciﬁc sample conﬁguration (droplet train) and
an advanced analysis method (surface-based MS).
4.2 Materials and Methods
4.2.1 Probe
A neural probe combining microelectrodes and a microﬂuidic channel system
(monolithic integration) has been designed and assembled. The distal tip includes
a T-junction droplet generator which enables the collection and the extraction
of ECF-containing ﬂuid plugs separated by an inert oil (perfuloromethyldecalin,
PFD). Extensive explanation regarding the fabrication process as well as char-
acterization of the system can be found in in chapters 2 and 3. Compared to
the precedent probe design, an additional ﬂuidic channel was bonded (EPO-TEK
301-2FL, Epoxy Technology) on the same surface than the one containing all
the active elements, its outlet being in close proximity to the sampling inlet
(300 μm). It is made of a fused silica capillary (ID = 50 μm and OD = 196 μm)
and is used for the perfusion of a low ﬂow saline solution (0.9 % NaCl) in the
area where the microsampling occurs. The capillary is smaller than the width
of the probe (240 μm) which makes it compliant with the system compactness
and minimally invasive feature. Figure 4.1 (a) shows schematically the neural
probe device during collection of brain-ﬂuid samples. The neural probe includes
two microﬂuidic entries (proximal side) which can be operated separately via
two pressure-driven reservoirs (Fluigent, module MFCS-MZ) ﬁlled with PFD. Two
fused silica capillaries (ID = 250 μm, OD = 360 μm and length = 40 cm) connects
the probe microﬂuidic entries with the reservoirs. The collection capillary is
ﬁlled with brain ﬂuid samples while the injection capillary is ﬁlled with PFD only.
This system enables to apply a positive or negative pressure (relatively to local
pressure) on the microchannels ﬁlled with PFD, thus controlling the droplet gen-
eration process occurring at the probe distal tip (Petit-Pierre et al. 2016). Figure
4.1 (b) shows the distal tip of the neural probe including the main elements
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Figure 4.1 (a) The brain-ﬂuid samples are extracted using the neural probe and collected in
a capillary. The samples are organized in a droplet train separated by PFD. The system is
controlled by two pressure pumps. (b) The perfusion capillary is situated in close proximity
to the main elements included on the neural probe distal tip. The dashed line shows the path
of the injected perfusate before being recollected in the sampling inlet (push-pull function).
(c) A drop of saline solution is released via the perfusion capillary demonstrating the
functionality of the system. (d) 3D exploded view of the interface unit comprising the neural
probe clamped between the bottom and the top parts.
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such as the sampling inlet, the microelectrodes and the perfusion capillary. The
pathway of the injected perfusate before being recollected in the sampling inlet
is represented by the dashed line. On ﬁgure 4.1 (c), a drop of saline solution is
released via the same capillary demonstrating the functionality of the system. It
can be noted that the drop efﬁciently wets the probe tip including the sampling
inlet.
4.2.2 Interface Unit
Polymer-based neural probes are often difﬁcult to interface because they are
mechanically ﬂexible and therefore difﬁcult to manipulate or to connect to harder
materials. We solved this issue by designing an interface unit particularly small
and light allowing for a reliable connection to the electrical contacts as well
as the ﬂuidic microchannels of the probe. Figure 4.1 (d) shows an exploded
3D view of the main elements of the interface unit in which the probe can be
clamped after connecting the top and bottom part. Four ﬁxation screws are used
to connect the parts together while the electrical connection is made with gold
spring contacts. The materials used to build the interface unit were chosen for
their good biocompatibilities (peek, stainless steel, silicone, gold) which makes
the system compliant with in vivo experimentation.
4.2.3 In Vivo Experiments
All experiment procedures were performed in accordance with the local animal
care authorities. A Sprague Dawley female rat (Charles river laboratory) weight-
ing 270 g was included in the experiment. The procedure was performed under
Isoﬂurane anaesthesia (4 % at induction, 2 % for maintenance) and included,
prior to any surgical act, a preliminary analgesia by buprenorphine injected under
the neck skin (Temgesic, 0.1 mg/kg). The subject was ﬁxed in a stereotactic frame
allowing to precisely target and reach the brain striatum while maintaining the
anesthesia. Stereotactic coordinates were set to + 0.5mm anterior, + 3.0mm lat-
eral and - 5.0mm ventral from bregma and the toothbar was set to - 3.3mm. First
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a craniotomy was performed on the subject using a drill; the external diameter of
the hole being relatively small with 0.8mm. Then the probe was implanted slowly
in the tissues while injecting the saline solution through the perfusion capillary
at a constant ﬂow rate of 50 nL/min in order to avoid clogging. Two minutes
after the target area was reached, the droplet sampling system was turned on.
During this phase, a positive pressure Pin = 50mbar and a negative pressure Pout
= −400mbar was applied (relatively to the local pressure) during 20min. 10 s
prior to starting the sampling, saline solution (0.9 % NaCl) was injected at a
ﬂow rate of 100 nL/min using the perfusion capillary. The saline perfusion was
maintained during the entire sampling procedure. After the sampling, the probe
was slowly retracted from the tissues. After the procedure, the rat brain was
transcardially perfused with a 4 paraformaldehyde containing saline solution.
25 μm slices were cut from the brain in the region of the implantation using a
Microtome (Leica biosystems) and placed in a sodium azide solution. The slices
were ﬁrst separated and stained (1min in cresyl violet dye) and then rinsed with
ethanol and toluol solvents. At the end of the experiment, the collection capillary
in which the droplets were collected was disconnected from the probe and stored
at - 20 °C. Particular level of attention was provided to maximize the animal
well-being along the in vivo experiment phase.
4.2.4 Analysis Method
4.2.4.1 Parylene Base Plate Fabrication
One of the fundamental feature of the neural probe presented in this work is to
maintain a high temporal resolution by keeping a spatial separation between each
collected droplet. A focus of this work was therefore to maintain this separation
as well as the correct order between droplets at every step of the analytical
process. For this purpose, a parylene-based substrate was developed and built
using microfabrication methods. A ﬂoat glass wafer was ﬁrst piranha cleaned,
and then coated with a 2 μm parylene layer. An Excimer laser (Optek LSV3) was
then used to drill 20 μm holes with a speciﬁc pattern on the parylene membrane.
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The laser parameters were adjusted in order to drill the holes until reaching the
ﬂoat glass wafer without altering its surface (power 2.5 kJ, attenuation 50 %, 15
repetitions, repetition rate 50Hz). Argon gas protection was used in order to
limit redeposition of the burned waste on the substrate. After manufacturing
the parylene base plate comprised a grid of holes equally spaced according to an
optimized pattern which could efﬁciently capture aqueous droplets.
4.2.4.2 Droplets Distribution Procedure
The developed parylene base plate described above allowed to easily distribute,
one by one, the droplets on the parylene membrane thus avoiding any cross-
contamination or loss of order. As showed in ﬁgure 4.2 (a), the droplet distri-
bution procedure consisted in slowly moving the collection capillary ﬁlled with
brain-ﬂuid samples parallel to the parylene surface while applying a positive ﬂow
of 0.02 μl/min using a syringe pump (Cetoni, Nemesys). A parylene base plate
typically includes 2 rows of 5 similar holes, the holes being 2mm spaced (x and y
direction) while the beginning and the end of the series are signalled by a cross
shape (laser machined). In order to validate this novel, tailor-made parylene
base plate and accompanying distribution method, a red-colored water droplet
enclosed between 2 PFD plugs stored in a capillary was distributed over a pary-
lene hole and monitored until complete drying. Figure 4.2 (c) shows a sequence
of images during which the drying process occurs (140 s, at room temperature
under microscope light). The PFD (clear liquid) evaporates rapidly (35 s) while
the red-colored droplet takes longer to dry (140 s). This is due to the high afﬁnity
of the PFD with the parylene membrane tending to spread the oil and increase
the exchange surface while the contrary occurs for the water droplet. A slight
recentering of the water sample over the parylene hole occurs during the ﬁrst
20 seconds which is beneﬁcial for the line by line analysis deﬁned with the laser
ablation system coupled to ICP-MS. The ﬁnal diameter of the dried spot is 180 μm.
Once dried, the samples are easier to manipulate and compatible with different
surface-based analysis methods. Compatible MS-based approaches would typi-
cally comprise matrix assisted laser ionization mass spectrometry (MALDI-MS),
secondary ion mass spectrometry (SIMS) or desorption electrospray ionization
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Figure 4.2 (a) Droplet distribution procedure on the parylene base plate. The brain-ﬂuid
samples are distributed on 20 μm drilled holes in a 2 μm thick parylene layer. This substrate
tends to ﬁx the aqueous samples in position while the parylene tends to pull away the PFD
oil (b) After drying, the brain-ﬂuid samples are laser ablated and analyzed using ICP-MS. (c)
Drying sequence which shows the evolution of a red-colored water droplet and the adjacent
PFD carrier phase (scale bar = 200 μm)
mass spectrometry (DESI-MS).
4.2.4.3 LA-ICP-MS
As a ﬁrst approach, the analysis were performed using an inductively coupled
quadrupole-based mass spectrometer (7700 series ICP, Agilent technologies)
coupled to a solid state laser ablation system (NWR213, ESI). This equipment
comprised a focused Nd:YAG system used to laser ablate the sample material.
The resulting products were then transported by helium (carrier gas) into the
inductively coupled plasma (ICP) which ionized the samples. The positively
charged ions were then extracted from the plasma and analyzed in a quadrupole
mass spectrometer (MS) which separated them with respect to their mass-to-
charge ratio to be ﬁnally detected by the ion detector. This system is known for
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detecting metals and several non-metal elements at extremely low concentration
(< 1 ppm) and is commonly used to perform cerebral bioimaging on brain
tissue sections (J. Sabine Becker et al. 2007). The parameters used to perform
the analysis of the brain-ﬂuid samples were deﬁned as the following; laser
energy density 5.2 J/cm2, energy output 17 %, laser focus spot size 100 μm, laser
pulse duration 20 ns, repetition rate 20Hz, scanning speed 100 μms−1 and the
carrier gas ﬂow rate 800ml/min, MS acquisition rate 1Hz. Two-dimensional (2D)
imaging was performed on the previously described parylene base plate after the
distribution of the brain-ﬂuid samples as showed in ﬁgure 4.2 (b). A deﬁned
area (10mm x 2mm) comprising 5 spots of interest as well as 5 control spots
was laser ablated in 3 passes (space between 2 spots = 2mm, distance between
2 lines = 1mm). The ﬁrst pass performed the measurement over the 5 spots
of dried brain-ﬂuid samples, the second pass was set over an area covered with
parylene only and the third pass went over 5 control spots constituted of saline
solution (0.9 % NaCl). All data were processed using Matlab and visualized using
MSiReader (Robichaud et al. 2013).
4.2.4.4 Quantiﬁcation
A standard calibration solution (Multi-element 2A, Agilent technologies) was used
to generate the calibration curves employed for quantifying the metal elements
found in the brain-ﬂuid samples. Deionized water solutions with known concen-
tration of metal standards (27 elements, 100 ngmL−1, 1 μgmL−1 and 10 μgmL−1)
were prepared. In order to mimic the ﬁnal conﬁguration of the in vivo collected
samples, droplet trains of standards solution separated by PFD plugs were pre-
pared using a ﬂow focusing system driven by 2 syringe pumps (Cetoni, Nemesys).
The droplets were collected in capillaries and then distributed over a parylene
base plate according to the process described in paragraph 4.2.4.2. LA-ICP-MS
analysis was performed on these samples and calibration curves were constituted
considering the maximum concentration value averaged over 5 droplets.
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4.3 Results
4.3.1 Acute Neurochemicals Sampling
Acute neurosampling in rat brain tissues using an advanced droplet collection
system included within a polymer-based probe was successfully demonstrated
for the ﬁrst time. Figure 4.1 (a) shows a portion of a collection capillary ﬁlled
with brain-ﬂuid samples separated by PFD segments. We observed a regular
spacing between the samples while the volume of each sample is similar with
an average of 17.9 ±1.8 nL (mean ± SD, n= 10). Interestingly, a change of the
capillary inner surface properties occurred. Indeed, prior to use, the inner surface
of the collection capillary was rendered hydrophobic using a silanization process.
In preliminary tests, the PFD segments showed high afﬁnities with the inner
surface. After the passage of the ﬁrst brain-ﬂuid samples, we noticed the contact
angle between the glass surface and the PFD was rather 135 ±5°which conﬁrmed
the inner surface of the capillary returned to a hydrophilic state. This rapid
change is probably due to the binding of proteins against the inner capillary
glass surface. Since the only liquid injected at the sampling spot is a saline
solution (0.9 % NaCl), this also proves qualitatively that the collected liquid
samples captured molecules from the ECF. Figure 4.3 (a) shows the surgical setup
during a measurement session. The neural probe is maintained in the interface
unit which is ﬁxed to the stereotactic-guided arm and can therefore be precisely
implanted in the targeted brain area (striatum). Figure 4.3 (b) shows a coronal
slice selected from this set which comprises the probe track in the tissues. The
entry point as well as the end of the probe course can be identiﬁed in the upper
brain structures (cortex region) and in the deeper region (top and bottom arrows,
respectively). The probe track is difﬁcult to identify, more particularly in the
deeper region (striatum) were the impact on tissues is hardly distinguishable.
This proves the approach is minimally invasive. The probe tip location is free of
any void which conﬁrms that no cavities are created by the perfusion and that a
tight link between the probe and the tissues probably occurs.
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1mm
(a) (b)
Figure 4.3 (a) Surgical setup during left brain hemisphere implantation on a rat. The neural
probe is maintained in the interface unit which is ﬁxed on the stereotactic arm. (b) Stained
left brain hemisphere after implantation of the neural probe. The black arrows represent the
entry point and the end of the probe tip when inserted in the cerebral tissues.
4.3.2 Analysis of In Vivo Collected Samples
After the sampling process was completed, the brain-ﬂuid samples were dis-
tributed on the parylene base plate according to the procedure described in
chapter 4.2.4.2. LA-ICP-MS mapping was performed on this substrate in order
to detect the presence of elements contained in the brain-ﬂuid samples. Figure
4.4 (a) describes the location of the samples on the parylene base plate prior to
analysis. The upper section comprises the 5 brain-ﬂuid samples (orange spots),
the middle section parylene only and the bottom section comprises 5 control
samples constituted of 0.9 % NaCl saline solution (white spots). The charts
represented in ﬁgure 4.4 (b) show the relative abundance (arbitrary unit) of
selected element as a function of the spatial positioning. We observe a strong
signal for sodium (Na), magnesium (Mg), potassium (K) and calcium (Ca) at
the position where the brain-ﬂuid samples were distributed. As expected the
signal of the K and Na is particularly high, these ions being the most abundant
in the brain extracellular ﬂuid (Eric R. Kandel et al. 2013). As expected, no
signal is observed in the parylene-covered region (second row of the laser trace,
every charts). The chart of the Na is of particular interest since the signal is also
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Figure 4.4 (a) Samples conﬁguration prior to analysis. The upper section includes the 5
brain-ﬂuid samples (orange spots) while the bottom section comprises 5 control samples of
saline solution (0.9 % NaCl, white spots). (b) Relative abundance (a.u.) of the elements Na,
Mg, K, Ca and Hg (negative control) found on the brain-ﬂuid samples.
present over the samples containing the perfused saline solution only (0.9 %
NaCl, control). This was expected and is conﬁrmed by the charts referring to
other elements which do not present any signal on the same region. The last
chart of ﬁgure 4.4 (b) shows the relative abundance of mercury (Hg) well-known
as a neurotoxic metal (Michalke et al. 2010). We clearly conclude that no trace
of Hg is present in the brain-ﬂuid samples which was expected and therefore
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constitutes a negative control. We observe that the width of each droplet on the
ﬁrst line is variable, the second droplet signal being particularly large, the third
being small. The third droplet dried spot was probably hit by the laser at the
edge of the beam path. This probably resulted from a slight misalignment of
the droplet dried spots with respect to the path of the laser beam. Figure 4.5
provides an example of such a misalignment. Figure 4.5 (a) shows the droplet
dried spots (black) and the location of the parylene holes (white crosses). Figure
4.5 (b) shows the laser beam trace over the dried spots (laser focus diameter
is 100 μm) while ﬁgure 4.5 (c) shows the equivalent droplet area "seen" by the
laser and the detection equipment. Finally, the signal output relative intensities
are represented on ﬁgure 4.5 (d). Apart from the sample initial volume, the
pixel widths depend on the speed of acquisition of the MS equipment as well
as the speed of the laser beam (acquisition rate = 1 Hz, laser beam speed =
100 μms−1). The method of analysis implemented in this study is particularly
sample 1 sample 4 sample 5sample 2 sample 3
laser trace
(a)
(b)
(c)
(d)
Figure 4.5 (a) Dried spot contours of the brain-ﬂuid samples (black) disposed over the
parylene base plate holes (signaled by white crosses). (b) Laser trace over the dried spots.
(c) Equivalent area of the dried spots seen by the detection equipment. (d) Final signal
readout after analysis (darker means more concentrated).
powerful in the sense it is not limited to a single analyte but can be implemented
on multiple elements with a single sample. Furthermore, it is compatible with
the constitution of a time-based molecular concentration record, reﬂecting the
brain neurochemichal composition overtime. In ﬁgure 4.6 (a), we present the
relative abundance charts for copper (Cu), iron (Fe) and zinc (Zn) taken from 3
successive brain ﬂuid samples. These metal elements are of particular interest
for the neuroscientists since links with degenerative diseases have recently been
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Figure 4.6 (a) Cu , (b) Fe and (c) Zn quantiﬁcation performed in three successive
brain-ﬂuid samples collected in vivo. For each element, the three graphs show (i) the trace
metal relative abundance (a.u.), (ii) the spatial element concentration readout after
detection and (iii) the temporal evolution of the concentration found in brain-ﬂuid samples
(sampling interval = 40 s).
highlighted. In particular Cu, Fe and Zn concentrations have been evaluated in
Parkinson’s disease (PD) mouse models (Matusch et al. 2010; Hare et al. 2009).
Figure 4.6 (b) shows the corresponding metal distribution over the analysed
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parylene base plate. Each peak is correlated with the position of the highest color
intensities found in ﬁgure 4.6 (a). Figure 4.6 (c) shows the temporal evolution
of the concentration found in brain-ﬂuid samples (maximum value reached for
each peak). This reﬂects the neurochemical composition of the implanted region
overtime. The sampling interval was 40 s (sampling rate = 1.5 min-1). The metal
concentration values reported are relatively stable in time which conﬁrms the
measurement method proposed here is consistent. Indeed, over this lap of time,
we rather expect a constant biochemical composition of the cerebral tissues.
Second column of table 4.1 reports the mean concentration computed over the 3
brain-ﬂuid samples (mean ± SD) for each metal elements. We found for Fe 1.17
± 0.44×103 μgL−1, for Cu 1.58 ± 0.31 μgL−1 and for Zn (0.67 ± 0.03 μgL−1. We
compared these values with recently reported basal concentration level of metal
elements found in the rat hippocampus ECF measured using microdialysis (C. K.
Su et al. 2008; Chung et al. 2007). The mean Cu and Zn concentration found here
are in good agreement with the reported values (0.77 - 2.48 and 0.51 - 5.22 μgL−1,
respectively). Unfortunately due to the limited number of studies performed in
this ﬁeld no data was available for the concentration of Fe in rat brain ECF. In
our samples we measured Fe concentrations (1.17 ± 0.44×103 μgL−1) that were
3 orders of magnitude higher than for Cu (1.58 ± 0.31 μgL−1) and Zn (0.67 ±
0.03 μgL−1). In human cerebrospinal ﬂuid (CSF), Fe baseline concentration is
reported to be in the range of 22-235 μgL−1 which is only slightly higher than
Cu and Zn with 18.2-34μgL−1 and 17-32.9 μgL−1, respectively (Michalke et al.
2010). These values, which however pertain to the human CSF, indicate that
the Fe concentration measured in our samples is abnormally high. This might
be due to local damage to the brain microvasculature which may have caused
micro-release of blood in proximity with the sampling inlet of the probe (residues
of red blood cells are known for their high Fe concentration). When analysing the
concentration of metal elements in a PD animal model, Hare et al. also described
similar increase of Fe concentration localized around the needle track (Hare et al.
2009).
85
Chapter 4. In Vivo Neurochemical Sampling
Table 4.1 Mean Fe, Cu and Zn concentration found in the 3 the brain-ﬂuid samples (mean
± SD). The values are compared with the metal concentration found in ECF matrix from rat
hippocampus.
element brain-ﬂuid samples ECF rat
(μgL−1) (μgL−1)
Fe 1.17 ± 0.44×103 -
Cu 1.58 ± 0.31 0.77 - 2.48
Zn 0.67 ± 0.03 0.50 - 5.22
4.3.3 Discussion
In this study we demonstrated a novel method for in vivo acute neurosampling
using an advanced neural probe system combined with a MS-based detection
method. The associated analysis platform comprises a speciﬁcally developed
parylene base plate which allows for an efﬁcient brain-ﬂuid sample isolation
while maintaining the droplets order and avoiding cross-contamination. The
ﬂat sample conﬁguration makes it potentially compatible with multiple surface-
based analysis method. Although we used ICP-MS in this work, the parylene
base plate could easily be adapted and used in another spectroscopic-based
equipment. For instance, MALDI-MS would be compatible and widen the range
of analysis, allowing the identiﬁcation and quantiﬁcation of larger molecules such
as proteins or metabolites. The off-line measurement approach implemented in
this work is interesting since it drastically simpliﬁes the in vivo measurement
phase. Disconnection of the collection capillary from the probe and storage
at −20°C of the droplet train was demonstrated to be particularly convenient.
Distribution of the collected droplets on the parylene base plate even weeks
after the implantation could be easily performed without affecting the samples.
Another major advantage is that the brain-ﬂuid samples are enclosed between
PFD plugs in a glass capillary and thus fully isolated from oxidation which often
occurs on molecules such as neurotransmitters (e.g the Dopamine degradation to
Dopamine o-quinone). A limit of the current method lies in the distribution of the
droplets on the parylene base plate which is a manual operation. It introduces
variability in the positioning of the droplets on the grid of holes. An option to
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overcome this limitation would be to automate the droplet distribution process
by controlling the relative position of the capillary on the grid, possibly using a
robotic arm. Precisely controlled positioning of the capillary, combined with a
constant positive ﬂow should result in a regular distribution of the droplets over
the parylene base plate. During preliminary testing of the distribution process,
we have noticed that even in the absence of holes, it was possible to immobilize
droplets and locally distribute solutes on the parylene ﬁlm. Automating the
distribution procedure could therefore allow to eliminate the need for performing
the holes in the parylene layer, thus simplifying the fabrication process. A major
attribute of the neural probe is related to its unique droplet collection system.
This sampling approach is compatible both with high temporal resolution, but
can also be operated in a slow, "on-demand" mode. Various applications can
be envisaged to monitor biological events such as synaptic neurotransmission
or changes in the basal chemical composition, which occur at very different
time scales (milliseconds vs. hours). The segmentation of the collected liquid
avoids Taylor dispersion and maintains the temporal history of the samples.
This approach however requires the droplets to remain tightly separated. In
the current device, the temporal resolution is deﬁned at 40 s which is the lapse
of time between two consecutive sampling of interstitial brain ﬂuid. However,
merging of droplets occurs in the zone where the collection capillary is connected
to the neural probe outlet. This is due to the difference of area between the
probe microchannel cross section (40 μm x 80 μm) and the inner diameter of the
collection capillary (ID = 250 μm). Consequently, around 20 droplets (Volume =
0.84 nL) merge at this speciﬁc point until the constitution of a larger droplet, big
enough to be transported by the carrier phase (PFD). This constitutes a loss of
temporal resolution. A way to address this issue would be to reduce the fused
silica capillaries dimension (e.g. ID = 50 μm) thus reducing the gap of area
between both cross sections. This would however require to redesign another
connector used at this ﬂuidic junction and, possibly, the probe itself to facilitate
the integration. As shown in ﬁgure 4.6 (a), the inner surface of the collection
capillary, which is initially hydrophobic following silane gas treatment, becomes
hydrophilic after the passage of the liquid sampled in the brain. This change
in surface properties of the capillary inner wall may as well contribute to the
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contact between droplets. Improving the capillary wall hydrophobic properties
could address this limitation. This could be achieved by the deposition of a
stable hydrophobic ﬁlm (1 - 2 μm) on the inner wall of the capillary. The
role in brain function of major cations, such as Na+, K+, Ca+ and Mg2+ have
been thoroughly characterized. Although less studied, transition metal elements
are also known to play critical roles in synaptic transmission, and might be
implicated in neurological diseases (Cheng Kuan Su et al. 2010; Burdette et al.
2003). For instance, Fe is a cofactor for a variety of enzymes responsible for the
synthesis of dopamine in synapses (Cheng Kuan Su et al. 2010; Moos, Nielsen,
et al. 2007; Moos and Rosengren Nielsen 2006), Cu is hypothesized to inhibit
the voltage-gated calcium channel of synapses and is responsible for impaired
neurotransmission when its concentration in too high (Cheng Kuan Su et al. 2010;
Zatta et al. 2007; Schlief et al. 2006) while Zn2+ is involved in the release of
the glutamate and γ-aminobutyric acid (GABA) release (Cheng Kuan Su et al.
2010; Mocchegiani et al. 2005; Takeda, Minami, et al. 2004; Takeda, Hirate,
et al. 2003). Although our system is compatible to different type of surface-based
analysis, LA-ICP-MS is a promising method for neuroscience applications since
it allows to draw a "picture" of trace elements distribution in a brain section at
a given time. Compared to the current approach consisting in mapping a brain
tissue sections from an animal sacriﬁced at a given point in time, the method
proposed here is minimally invasive and allows for multiple recordings performed
on a same animal. This is of particular interest when the focus of the study is
linked to neurodegenerative studies like Parkinson’s (PD) or Alzheimer’s (AD)
disease which develop over long time scale. Our approach doesn’t allow to
perform multi-site chemical mapping but it gives access to a 3rd dimension, the
time evolution, at a very precise location recorded in the brain which can be of
major interest when studying PD or AD.
4.4 Conclusions
In this chapter is demonstrated the ﬁrst in vivo validation of a microscale droplet
collection system included at the very distal tip of a neural probe. Neurochemi-
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cals present in the brain ECF of a rat were successfully sampled with this device.
A speciﬁc parylene base plate is proposed as an interface between the brain-
ﬂuid samples (organized in a droplet-train) and the surface-based detection
method. This parylene base plate allows for ﬁxing the droplets in position while
maintaining their order and avoiding cross contamination, thus guarantying the
time-history consistency of the sampling. This platform is potentially compati-
ble with multiple analysis systems using planar sample conﬁguration as target.
LA-ICP-MS was used to analyze the brain-ﬂuid samples. The results conﬁrmed
the presence of elements such as Na, Mg, K and Ca which are known for their
contribution in the regulation of biological processes at the synaptic level. Fur-
thermore quantiﬁcation (droplet by droplet) was demonstrated for the trace
elements Cu, Fe and Zn known for playing a role in neurodegenerative disease
development. The results obtained with this method are similar to concentration
values reported in the literature. The collected samples constituted a high res-
olution spatio-temporal pattern (droplets interval = 40 s) representative of the
neurochemical state at the tip of the implanted probe. This tool provides new
opportunities with the perspective to study electrical stimulation on tissues and
its related neurochemical response. This topic will speciﬁcally be addressed in
the next chapter.
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Chapter 5
Neurochemicals Recording During
Electrical Stimulation of Cerebral
Tissues
5.1 Introduction
The device demonstrated in chapter 4 enabled to successfully collect brain-ﬂuid
samples in vivo. In this chapter, further insight is gained through the establishment
of two models which allow to link the brain-ﬂuid samples analysis readout to the
actual species concentration in the tissues. Then, the results of the simultaneous
tissue electrical stimulation and neurochemical recording is reported. This chapter
is consequently subdivided in two distinct sections; (i) a modeling section and (ii)
an in vivo experimental section. The models developed in this chapter will allow to
characterize the droplet sampling rate and its relation to the probe efﬁciency. This
parameter (probe efﬁciency) is essential for comparing the device performances
against the actual recovery efﬁciency of existing microdialysis approaches. The
construction of this chapter slightly differs from the standard structure because
of its subdivision in 2 distinct parts. The end-discussion will consequently be
focused on the in vivo results rather than on the models outcomes. The models
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perspectives and limits are however addressed at the end of each concerned
sections (5.2.1 and 5.2.2).
5.2 Modeling
5.2.1 Droplet Evaporation Model
Neurochemical measurements typically rely on the estimation of the concen-
tration of species of interests such as neurotransmitters or ions involved in AP
transmission. In this section, a model is established to estimate and retrieve the
volume concentration (CV [ 1m3 ]) from surface concentration (CS[
1
m2
]) which is a
known value obtained from the analysis. This can be particularly useful when
only a portion of the dried spot is analyzed; despite an incomplete analysis the
initial droplet concentration could be retrieved anyway.
When a droplet is deposited on a ﬂat surface, different proﬁles are observed
which depend on the nature of the substrate, the ﬂuid surface tension and the
surrounding environment. As ﬁrst described by Picknett and Bexon, we identify 2
modes of evaporation for a sessile droplet in still air provided its mass is less than
about 1mg; (i) the Constant Contact Angle (CCA) and (ii) the Constant Wetting
Area (CWA) (Picknett et al. 1977). In the CCA mode, the droplet contact angle
remains constant during drying while in the CWA mode the wet area remains
constant throughout the process as depicted in ﬁgure 5.1 (a) and (b), respectively.
In our case though, the situation is not trivial since the PFD is also present during
a part of the evaporation cycle. From observations, we notice the droplet exhibits
a mixed-mode behavior which we can separate in two phases. In a ﬁrst phase
the droplet exhibits a CCA behavior until complete evaporation of PFD. Then,
in a second phase, the droplet transit to a CWA regime until complete sample
drying occurs. The PFD, which is denser than water ( ρ = 1972 k/m3), forms a
pillow around the droplet and modiﬁes the local interface properties. It seems
therefore reasonable to assume the presence of PFD in the ﬁrst phase tends to
render the situation super-hydrophobic, seen from the droplet (McHale et al.
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θ
0
Constant contact angle (CCA) Constant wetting area (CWA)
θ
0
(a) (b)
Figure 5.1 (a) Constant contact angle mode in which the contact angle θ remains constant
and equal to θ0 throughout the evaporation process. (b) Constant contact area in which the
wet surface remains constant while θ decreases during the drying process.
2005). CCA regime is in all likelyhood caused by the presence of the hydrophobic
surrounding PFD. In such a situation, the ﬁnal dried spot radius is deﬁned by the
ﬁrst evaporation phase where the CCA mode occurs and the wet area decreases.
Figure 5.2 summarizes the different phases upon complete drying. Picknett and
Bexon proposed in 1977 a theoretical analysis allowing to predict the evaporation
rate of sessile droplets in the CCA mode (Picknett et al. 1977). Maxwell’s equation
describing the evaporation rate of a drop in an inﬁnite medium is given by:
dM
dt
=−4πDr (c0−ci ) (5.1)
where M is the mass of a sphere of radius r , D is the molecular vapor diffusion
constant in air, c0 the vapor density close to the sphere surface and ci far from
the sphere. As we are in the CCA mode, the contact angle is constant (θ = θ0)
and the relation can be written:
dM
dt
= −kE
C
r M
1/3
2ρ1/3
(5.2)
with
k = 4πD(c0−ci ) (5.3)
E =
(
3
π
(
1−cos(θ0)
)2(2+cos(θ0))
)1/3
(5.4)
93
Chapter 5. Neurochemicals Recording During Electrical Stimulation of
Cerebral Tissues
θ
0
r
R
PFD
water
R
f
R
f
(1) (2) (3)
time
W
e
t 
a
re
a
 r
a
d
iu
s 
R
CCA CWA
0
0
R
f
Figure 5.2 Droplet drying process and associated evaporation mode of a brain-ﬂuid sample
after distribution on the parylene base plate. In the ﬁrst phase (1) the water droplet of
radius r cohabits with the PFD and exhibits a contact angle θ0 with the surface. In this
phase the evaporation mode is assumed to be in a CCA regime. In the second phase (2), the
PFD is completely evaporated and the situation corresponds to a CWA evaporation mode.
At this stage the ﬁnal dried spot diameter (Rf) is already known as R remains constant. The
ﬁnal phase (3) is reached when the sample is dried. The graph shows the expected evolution
of the wet area radius R as a function of these three phases over time.
C
r
= 0,00008957+0,6333 ·θ0+0,116 ·θ20 −0,08878 ·θ30 +0,01033 ·θ40 (5.5)
where k, E , Cr and ρ (the sphere ﬂuid density) are constants. E is a constant
expressing the link between the mass M to the volume of the sessile drop (M =
ρ r
3
E3
). C is the evaporation capacitance of the equiconvex lens formed by the
sessile droplet and its image in the substrate. The expression of the ratio Cr is
given here for 0.175≤ θ0 ≤π as it covers most of the contact angles1. The equation
1Another relation is reported for θ0 < 0.175 in (Picknett et al. 1977)
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5.2 can be integrated which gives:
M =M0−
(
tkE Cr
3ρ1/3
)2/3
(5.6)
where t is the time. From the mass M we can extract the radius of the sessile drop
r with the relation:
r = E
(
M
ρ
)1/3
(5.7)
The ﬁnal wet area radius R reads then:
R = r ·cos
(
θ0− π
2
)
(5.8)
From there it is possible to compute the wet area radius over time during the ﬁrst
phase of drying, in the CCA mode. At the issue of this phase, the ﬁnal radius Rf of
the dried spot is known. The wet area radius R of a 21 nL (= 2.1×10−8 kg) water
droplet can be predicted with the set of parameters deﬁned in table 5.1.
Table 5.1 Parameters used in the dried spot model to predict the evaporation behavior of a
water droplet in presence of PFD.
parameter value units
M0 2.1×10−8 kg
ρ 1000 kg/m3
θ0 135 °
D 2.82×10−5 m2/s
c0 2.32×10−2 kg/m3
ci 1.21×10−2 kg/m3
Figure 5.3 shows the variation of R (wet area radius) over time as predicted by
the model (blue line). The model prediction has been compared to experimental
data acquired by monitoring the evaporation of a 21 nL water droplet on a
parylene base plate. The sample was prepared and extracted from a PFD-water
droplet train and distributed over a parylene base plate (free of hole). Optical
measurements (normal to the surface) of the wet area radius R evolution by image
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analysis using the software ImageJ was performed along the evaporation cycle.
The initial contact angle θ0 was evaluated at θ0 = 135 deg. The experimental
data are showed in ﬁgure 5.3 in orange. The image sequence during the droplet
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Figure 5.3 Variation of radius R over time during the evaporation of a water droplet (V
=21 nL) in presence of PFD. This situation is similar to the brain-ﬂuid samples drying
process. The blue curve is the model prediction while the orange curve comes from measured
experimental data. The prediction values are valid in the CCA mode, during the ﬁrst drying
phase.
drying cycle including the data from the image analysis is provided in ﬁgure 5.4.
The white circle is superposed to the contact area circle and its diameter value
displayed on each sub-ﬁgure.
5.2.1.1 Discussion
We notice the model is in good agreement with the experimental values recorded.
The ﬁrst phase (CCA mode) lasts for 97 sec while the second phase (CWA mode)
is shorter with 12 sec until the sample is dried. The model prediction becomes
imprecise near the transition between the CCA and CWA mode; the model predicts
96
5.2. Modeling
R = 118 μm
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t = 60 s t = 70 s
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R = 90 μm
t = 90 s
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PFD
Water
Figure 5.4 Image sequence of a water droplet (V =21 nL) during evaporation on a parylene
substrate, in presence of PFD. The wet area radius R (white circle) is measured at each time
step. These experimental data were compared to the R values predicted by the model.
a lower Rf (ﬁnal diameter) than the experimental values reached. We even notice
the Rf measured increases instead of remaining stable. This difference might be
explained by unanticipated surface tension phenomena occurring when the PFD
disappears and the system transit from a "gas-liquid(water)-liquid(PFD)-solid"
interface to a standard "gas-liquid-solid" interface. In this transition phase, the
contact angle probably quickly transits from the initial obtuse angle θ0 (= 135 deg)
to an acute angle. In a parylene-water-air systems, the contact angle has been
reported to be equal to θ = 89 deg (Orejon et al. 2011). This transition would
explain why the diameter increases until ﬁnding a new equilibrium position
(droplet pining) instead of remaining stable, as initially assumed by this model.
If the model correlates well with the data aquired, the inﬂuence of several
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parameters presented in this approach have not been tested. The inﬂuence of
the initial droplet volume or the impact of the presence of NaCl in the brain-ﬂuid
samples are central ones. It might therefore be advised to repeat the experiment
several times varying these parameters in order to validate its predictive behavior.
This would further allow to provide a model conﬁdence interval.
Similarly, the image analysis method implemented here is valid as a ﬁrst approach.
However, it can also generate imprecision when measuring Rf on the dried spot;
especially in the ﬁnal phase where the dried spot is never perfectly circular. Image
analysis tools could be used here to precisely monitor the surface change which
would be more relevant than extrapolating a diameter value. Another approach
would have been to monitor the loss of mass over time instead of measuring the
contact radius. This could have been implemented by placing the substrate on a
precision lab scale as performed in initial studies (Picknett et al. 1977; Birdi et al.
1989). However, since our system combines two distinct ﬂuid phases (PFD and
water) both prone to evaporation, this approach is not implementable here as it
would be difﬁcult to distinguish the evaporation of the PFD from the evaporation
of the water droplet.
5.2.2 In Vivo Species Diffusion Model
The model provided in the previous section allows to link the output of the
detection method to the actual concentration of a brain-ﬂuid sample. Now one
may ask which ratio of the actual ECF concentration found in the cerebral tissues is
indeed contained in the brain ﬂuid samples. Unlike microdialysis, the in vivo ECF
collection performed by the neural probe is similar to the push-pull approaches
(W. H. Lee, Thomas R. Slaney, et al. 2013; T. R. Slaney et al. 2011; Kottegoda
et al. 2002). In push-pull approaches a solution (or perfusate) is continuously
perfused in the cerebral tissues whereas, at the same time, continuous liquid
sampling is performed with an adjacent capillary. Thus the collected liquid is
a fraction between the ECF-exchanged molecules and the perfusate content.
Evaluating how much of the ECF is retrieved from the cerebral tissues is of major
interest in our case, as the method involves perfusing liquid in the cerebral tissues.
98
5.2. Modeling
In microdialysis, the ratio between the actual extracellular concentration and the
dialysate is named "relative recovery" or "probe efﬁciency". This value depends
on the ﬂowrate of the dialysate but typically remains under 40 % at usual values
(e.g. at 1 μLmin−1) (Chefer et al. 2009).
The diffusion equation can be employed in order to predict the relative recovery
of the neural probe. The Fick’s law (or diffusion equation) describes the diffusion
of a solute in a viscous medium at steady state conditions. The relation postulates
the ﬂux goes from the high concentration region to the low concentration region,
across the concentration gradient. The law reads:
J=−D∇φ (5.9)
where J is the the diffusion ﬂux vector, D the diffusion coefﬁcient and φ the
concentration of the solute. Under the assumption of low Re number, the diffusion
of spherical particles through a liquid coefﬁcient is deﬁned by the Stokes-Einstein
relation:
D = kBT
6πηa
(5.10)
with kB the Boltzmann constant ( = 1.38064852×10−23 JK−1), T the temperature,
η the dynamic viscosity and a the particle radius. In steady state conditions, the
continuity equation reads:
∂φ
∂t
=−∇·J (5.11)
which can be written, with the precedent deﬁnition given in 5.9:
∂φ
∂t
=−∇· (−D∇φ)=D∇2φ (5.12)
and which expresses the variation of the solute concentration over time.
In the following we use this mathematical description to evaluate the relative
recovery of the neural probe. In particular, the evaluation of the time taken by
an analyte to diffuse from the cerebral tissues to the sampling inlet of the neural
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probe is of major interest. We will consider here a spherical drop of perfusate
with a known radius rdrop permanently in place in the cerebral tissues as shown in
ﬁgure 5.5 (a). As a ﬁrst approach, we will neglect any sources or sinks present in
the system. This situation can equivalently be represented by a mono-dimensional
model along the x axis considering the probe tip as an inﬁnitely small sampling
point at the position x = 0. At initial conditions, the perfusate mean concentration
of an analyte i contained in the brain is zero. At the position x = rdrop, the analyte
concentration rises to Φi and remains constant in an inﬁnitely long reservoir
representing the cerebral tissues.
probe tip
cerebral 
tissues
r
drop
Concentration
x
Φ
i 
0
x
y
cerebral tissuesperfusate 
drop
r
drop
perfusate 
drop
(a) (b)
Figure 5.5 Diﬀusion model from the cerebral tissues to the neural probe inlet. (a)
Bi-dimensional representation of the system including the perfusate drop of radius rdrop as
well as the probe tip inserted in cerebral tissues. (b) Mono-dimensional representation (along
the x axis) of the initial concentration distribution of an analyte n in the same system. At
the position r = rdrop, the analyte concentration rises to Φi , its concentration in the brain.
Using the differential equation 5.12 in the mono-dimensional case with the
parameters deﬁned in table 5.2 we can predict the diffusion of a Ca ion in the
perfusate drop (Lide 2004; Weast 1989). We assumed here the perfusate drop
is a pure water spherical volume of radius rdrop = 100 μm (e.g. of volume =
4.2 nL). The following boundary conditions were used in the model: (i) the
molecular diffusion ﬂux was ﬁxed to zero at x = 0 (∂φ∂x = 0 at x = 0) and (ii) an
inﬁnite reservoir of diffusing species was considered at x ≥ rdrop. The resulting
concentration curve Φ (relative to ΦCa∞, the Ca concentration in the tissues at
an inﬁnite distance from x = 0) at initial condition (t = 0) and its evolution over
time (from t = 0.1 s to t = 100 s) is provided in ﬁgure 5.6. Ca concentration in the
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Table 5.2 Parameters used in the diﬀusion model to predict the diﬀusion of ionic species
(Ca, K,Mg) from the cerebral tissues towards the probe inlet.
parameter value units
rdrop 100×10−6 m
aCa 231×10−12 m
aK 280×10−12 m
aMg 173×10−12 m
T 37 ◦C
kB 1.380648×10−23 JK−1
η 6.915×10−4 Pas
perfusate drop (left to the dashed grey line) tends to increase and equalize ΦCa∞
over time. After 100 s, the concentration at the sampling spot (x = 0) reaches
85 % of ΦCa∞, the concentration outside of the perfusate drop, in the cerebral
tissues at an inﬁnitely distant location. Under the previously deﬁned conditions
the time to reach a relative recovery of 50% and 85% amounts to 7.6 s and 96.3 s,
respectively. Table 5.3 compares the time needed to reach these relative recovery
values for Mg and K ionic species. We notice signiﬁcant differences regarding the
time to reach a relative recovery of 85 % which is explained by the difference in
size of the considered ionic species.
Table 5.3 Predicted time to reach 50 % and 85% relative recovery in the sampling process
as a function of the considered species.
Species time to 50 % time to 85 %
rel. recovery rel. recovery
Mg 5.67 s 72.13 s
K 9.18 s 116.75 s
Ca 7.57 s 96.31 s
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5.2.2.1 Discussion
The model proposed in this section assumed the diffusion took place in water,
which is reasonable for the perfusate drop domain but less appropriate for the
cerebral tissues domain. In the cerebral tissues the diffusion coefﬁcient is reduced
compared to diffusion in water since the extracellular space comprises narrow
spaces and tortuosity limiting molecules motions (without even considering loss of
molecules through cellular uptake and binding or blood-brain barrier absorption).
The hindrance to diffusion in nervous tissues is generally characterized using the
tortuosity Λ which is the square root of the ratio between the free diffusion in
water D and the effective diffusion coefﬁcient D∗ (Harris et al. 1948; Safford
1977):
Λ=
√
D
D∗
(5.13)
The tortuosity is reported to range from 1.4 to 1.7 meaning D∗ accounts for a half
to one third of D, the free diffusion in water (Sykova et al. 2009). From these
values we can extrapolate that the time to reach a given concentration at the
sampling inlet should be longer than predicted by the model as the diffusion in
cerebral tissues is hindered by the tortuosity. The inﬁnite reservoir considered
in the model would therefore supply slowlier the perfusate drop. Dividing the
system in two spatial domains with two distinct diffusion coefﬁcients, one for the
perfusate drop and one for the cerebral tissue, could allow to enhance the model
precision, although this description won’t be implemented here.
Another simpliﬁcation made in this analysis is the omission to consider the sodium
contained in the perfusate drop. In term of viscosity, the NaCl 0.9 % is almost
similar to pure water, which should have a negligible impact on the model. For the
Na ion though, the concentration gradient will be lower than for any other species
and the molecular diffusion driving the ions towards the perfusate drop lower.
Although not implemented here, the Na distribution change over time could be
more precisely evaluated with this model by changing the initial condition its
concentration distribution over x.
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This analytical model also allows to deﬁne an appropriate sampling frequency
when collecting ECF molecules from the cerebral tissues. If the perfusate drop
in the tissues is spherical and of radius rdrop = 100 μm as assumed in this model,
the fraction of ΦΦCa∞ collected in the sampling probe after 100ms represents only
0.006. Consequently the sampling resolution can be largely decreased in order
to retrieve a larger fraction of the actual cerebral tissue Ca concentration in
the samples. It is therefore recommended to adjust the sampling period to 30 s
(f = 0.003Hz) in order to reach relative recovery values above 75 %, which is
already much higher than achieved with microdialysis approaches under standard
sampling conditions (Kennedy 2013).
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Figure 5.6 Time evolution of the Ca ions concentration (relative to ΦCa∞, the Ca
concentration at an inﬁnite distance from x = 0) in the perfusate drop. The grey dashed line
limits the perfusate drop domain from the cerebral tissue domain. At initial condition (t =
0 s), the perfusate drop (radius rdrop = 100 μm) contains no Ca ions. Then the Ca
concentration in the perfusate drop increases with time and tends to equalize ΦCa∞.
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5.3 Simultaneous Neurochemicals Sampling and Elec-
trical Stimulation
In chapter 4 was demonstrated the in vivo droplet collection of neurochemicals
using exclusively the microﬂuidic functions of the neural probe. In this section
we propose to electrically stimulate the cerebral tissues while continuously col-
lecting neurochemicals. The objective is to use the neural probe as a trigger of
neurochemical activity. Such a combined process could be of major interest for
the neuroscientists since direct correlation between neurochemical and electrical
activity in cerebral tissues will be observed at unprecedented temporal and spatial
resolution.
5.3.1 Material and Methods
5.3.1.1 Neural probe
The in vivo measurements were performed with a slightly modiﬁed version of
the neural probe compared to previously described in chapter 4, section 4.2.1.
An electrical connector by which the neurostimulation signal is transmitted to
the probe tip and the cerebral tissues was bonded to the probe proximal contacts
using conductive glue (Epotek H20E, Epoxy technology Inc.). The bonding was
further secured using Epoxy glue joining the connector base to the neural probe
proximal surface. This connector contacts 8 electrical tracks, each connected
to the distal electrodes according to the pairing chart provided in appendix A.1.
In term of microﬂuidics, the same pressure driving equipment units were used
(2x MFCS-MZ, Fluigent). PFD was used as the carrier ﬂuid. Two fused silica
capillaries (ID = 250 μm, OD = 360 μm and length = 40 cm) were assembled to
the probe via 2 microﬂuidic connectors (P-771, Idex HS). This solution allowed
for an efﬁcient disconnection and replacement of the collection capillary. The
neural probe also includes a perfusion capillary (ID = 50 μm and OD = 196 μm)
employed to inject perfusate in the tissues (saline solution 0.9 % NaCl) during the
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sampling process. Figure 5.7 provides an overview of the neural probe including
the new elements previously described. We notice the neural probe is ﬁxed
to the interface unit bottom part to facilitate manipulation and ﬁxation on the
stereotactic arm.
electrical 
connector
fluidic
connectors
neural 
probe
10 mm
interface unit
bottom part
Figure 5.7 Neural probe including the electrical and ﬂuidic connectors. The device is
bonded to the bottom part of the interface unit which facilitates handling during in vivo
experiments (ﬁxation to the stereotaxic frame).
5.3.1.2 Electrical Stimulation
An external pulse generator (Model 2100, A-M system) connected to the neural
probe was used to neuromodulate the cerebral tissues in direct proximity with
the device distal tip. Train of biphasic pulses of 300 μA amplitude (peak to peak)
and 2ms duration at a frequency of 60Hz were delivered during 60 sec as detailed
in appendix A.2. The signal was delivered by the largest stimulation electrode
(diameter d = 150 μm) of the probe distal tip. The counter electrode consisted in
a Pt wire electrode (diameter D = 100 μm) inserted in the superior region of the
cortex through the craniotomy hole.
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5.3.1.3 In Vivo Experiment
Three Sprague Dawley female rats (Charles river laboratory) weighting between
245 g and 250 g were included in this experiment. The measurements were
performed under Isoﬂurane anaesthesia (4 % at induction, 2 % for maintenance).
An analgesia by buprenorphine (Temgesic, 0.1 mg/kg, injected under the skin of
the neck) was performed on each subject before any surgical act. The subjects
were ﬁxed in a stereotactic frame and the stereotactic coordinates were set to
+ 0.5mm anterior, + 3.0mm lateral and - 5.0mm ventral from bregma with
the toothbar set to - 3.3mm to reach the brain striatum. After the craniotomy
(hole diameter 0.8mm), the neural probe was inserted slowly in the tissues while
injecting the saline solution through the perfusion capillary at a constant ﬂow
rate of 50 nL/min in order to avoid any clogging issues. Two minutes after
the target area was reached, the droplet sampling system was turned on. A
positive pressure Pin = 50mbar and a negative pressure Pout = −400mbar was
applied (relatively to the local pressure) during 20min. 10 s prior to starting
the droplet collection sampling, the saline solution was injected at a ﬂow rate
of 100 nL/min. The droplet sampling process was then started. 1min after, an
electrical stimulation was applied to the cerebral tissues for a period of 1min
(while maintaining the droplet sampling in parallel). 11min after the beginning
of the droplet sampling, electrical stimulation was applied again for a period of
1min. The droplet sampling procedure was continued for an additional 9min and
stopped 21min after its beginning. The saline perfusion was maintained during
the entire sampling procedure. After the phase, the probe was slowly retracted
from the tissues and the animal sacriﬁced. At the end of the experiment, the
collection capillary in which the droplets were collected was disconnected and
stored at - 20 °C. Particular attention was provided to maximize the animals well-
being during the experiment. All the procedures were performed in accordance
with the local animal care authorities.
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5.3.1.4 Analysis Method
The anaylsis of the collected brain-ﬂuid samples was performed using an ICP mass
spectrometer equipment (7700 series ICP, Agilent technologies) coupled to a solid
state laser ablation system (NWR213, ESI) which comprises a focused Nd:YAG
system used to laser ablate the sample material. The following parameters were
set; laser energy density 4.27 J/cm2, energy output 23 %, laser focus spot size
50 μm, laser pulse duration 20 ns, repetition rate 20Hz, scanning speed 50 μms−1,
carrier gas ﬂow rate 800ml/min and MS acquisition rate 1Hz. After the in vivo
collection, the brain-ﬂuid samples were distributed on a similar platform than the
previously described parylene base plate (chapter 5, section 4.2.4). The parylene
base plate comprised 20 holes in a row, each of 20 μm diameter, drilled using
an Excimer laser (Optek LSV3). The brain ﬂuid samples were distributed and
dried on this platform. Two-dimensional imaging was performed on the dried
spots, each laser pass being separated by 50 μm, giving a pixel resolution of 50 x
50 μm2. All data were visualized using MSiReader and processed using Matlab
(Robichaud et al. 2013).
5.3.2 Results
The samples extracted from the cerebral tissues comprised 3 sets of droplet trains.
The 1st set included 16 brain-ﬂuid samples, the 2nd 17 while the 3rd included
11 brain-ﬂuid samples. The ICP mass spectrometry analysis on these samples
revealed the presence of Na, Mg, K and Ca in the brain-ﬂuid samples in signiﬁcant
relative abundance for every set of droplets. Traces of Mn, Fe and Cu metals were
found as well, the signal of Cu being in general stronger than the other ones. No
traces of Hg were found in any samples, as expected, which constitutes a negative
control. These results are similar than found in chapter 5 which consolidate the
validity of our ﬁndings. Figure 5.8 shows the relative abundance maps for the
elements Na, Mg, K and for every set of extracted droplet trains (only the 8 ﬁrst
droplets are shown).
As it can be observed on the heat maps of ﬁgure 5.8, the spatial resolution is
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Figure 5.8 Relative abundance of Na, Mg and K found in the brain-ﬂuid samples after
ICP-MS detection. The results are provided for 3 successive sets of independently collected
brain-ﬂuid samples ((a), (b) and (c)). (Only the ﬁrst 8 brain-ﬂuid samples are shown here)
drastically enhanced compared to the results from chapter 5 (ﬁgure 4.4). A
detailed three-dimensional plot of a single dried spot (second dried spot) is
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provided in ﬁgure 5.9. The peak height is proportional to the relative abundance
of the Mg element over the dried spot surface. We notice the signal intensity
distribution is relatively homogeneous over the dried spot surface; no coffee-stain
effect is detectable.
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Figure 5.9 Selected dried spot from the second set of samples represented in 3
dimensions.Mg relative intensity is represented on the vertical axis.
In ﬁgure 5.10 is provided the detection results of a complete time sequence
including the two periods of electrical stimulation. Figure 5.10 (a) shows the
relative abundance for the Mg on the 16 dried spots of the ﬁrst set of samples.
The time lapse between two successive brain ﬂuid samples was evaluated at t =
100 s. Consequently, the maximum relative abundance peak value extracted for K,
Na, Mg and Pt is provided as a function of the time in ﬁgure 5.10 (b). These plots
refer to the temporal in vivo evolution of the neurochemicals over a sampling
period of 15min with two electrical neurostimulation periods of 1min (between
sample 2 and 3 and between 12 and 13). We observe that K relative intensity
signiﬁcantly increased as a response to the electrical stimulation while Na and
Mg remained stable.
Interestingly, Pt relative abundance also increases during both periods of neu-
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Figure 5.10 Detection results of in vivo collected brain-ﬂuid samples (1st set) with
simultaneous electrical neurostimulation of the tissues. (a) Mg relative abundance
distribution found in the collected brain-ﬂuid samples using ICP mass spectrometry. This set
comprised 16 brain-ﬂuid samples each separated by a lapse of time of 60 s. (b) Temporal
evolution of the maximum relative abundance found in each brain-ﬂuid sample for K, Na,
Mg and Pt. The periods of electrical stimulation as deﬁned by the experimental protocol are
provided at the bottom of the ﬁgure.
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rostimulation, in correlation with the K increase. It is assumed that during
stimulation Pt particles are released in the tissues which would explain the re-
ported increase. This is an important result which conﬁrms the stimulation
periods are indeed synchronized with the applied stimulation periods as deﬁned
by the experimental protocol (1min stimulation at t = 1min and t = 11min). We
can therefore consider the Pt trace as a "marker" of the stimulation periods.
Apart from K and Pt, no other elements showed a signiﬁcant answer to the
neurostimulation phases (the elements assessed included Ca, Mn, Fe, Cu and Zn).
Although not provided here, similar results were observed in each of the 3 sets
of brain-ﬂuid samples. In particular, the correlation of the electrical stimulation
periods with K increase and Pt increase is reported in every set of results which
further validates our ﬁndings.
5.4 Discussion
Most cells maintain an internal environment negatively charged relative to the
extracellular space. This is the case for neurons which keep a resting potential
set to -70mV as reported in the experimental work of Hodgkin and Huxley
on nerve conduction (Hodgkin and Huxley 1952). This negative potential is
maintained thanks to the ion pumps and voltage-gated ion channels; K+ ions are
pumped in the cell while Na+ ions are removed continuously resulting in a stable
resting membrane state. When an AP propagates along an axon, the neuron
cell membrane goes through a depolarization phase (internal potential starts
to increase) and reach, at the AP peak, a positive potential of +40mV. During
this phase, the Na+ channels are open and a Na+ inﬂux is observed towards the
inner compartment of the axon. After this peak phase, the K+ channels open and
the K+ ions consequently leave the axon and penetrate the extracellular space;
the inner potential of the neuron therefore decreases to reach a hyperpolarized
state of -75mV, 5mV under the resting potential. This state persists for a few
milliseconds before the K+ channels closes and the neuron stabilize at its resting
potential again.
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The electrical stimulation applied during this experiment probably induced a
depolarization of the neurons followed by a hyperpolarization. In particular it
seems the neurons are maintained in a hyperpolarized-locked state. This would
explain the signiﬁcant rise of extracellular K signal measured simultaneously
with the stimulation periods while the Na+ signal remained stable (and didn’t
decrease due to depolarization as expected). Prior to hyperpolarization, the
neuron should experience a depolarization phase accompanied with a local
extracellular depletion of Na+ ions. In our measurements we didn’t detect such
a depletion though. This is probably explained by the very high Na+ content
found in the ECF (145mmol) which renders small variations hardly detectable. In
comparison, K+ concentration in ECF is 30 times lower with (4.5mmol) (Boron
et al. 2017). It is to mention Na detection is further hindered by the local injection
of a saline perfusate during the sampling which tends to constantly renew the
extracellular Na content.
It is interesting to put these results in perspective with the DBS treatment for PD
and Essential Tremors (ET). In this therapy, electrical stimulation at precise brain
locations (e.g. STN and Globus Pallidus (GPi)) is delivered which drastically
reduces the symptoms of these neurological disorders. The therapeutic mecha-
nism behind the treatment is not clearly understood although it is clinically very
effective. One of the ﬁrst stated mechanism was that the stimulation produced
an inhibitory effect on the stimulated target which was well aligned with the im-
proved symptoms observed after thalamotomy or pallidotomy (surgical ablations)
(Montgomery et al. 2008; McIntyre et al. 2004). Although this hypothesis is
disputed and that many other mechanisms of action have been proposed as well,
this would go in the same direction than our results stating that the electrical
stimulation pattern applied tends to hyperpolarize and "paralyze" the signals
propagation of the direct neural environment around the probe electrode. As a
future perspective of this technology, using the recording electrodes included on
the device could help to decode the functional mechanism lying behind electrical
stimulation. Indeed, this would provide valuable information regarding the elec-
trical activity (ﬁring rate) of a stimulated neuronal network and thus improve
our understanding of the mechanism involved here.
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Finally, it is interesting to note the extension of the electrical stimulation in the
tissues was probably limited to roughly a half sphere of 1mm diameter over the
stimulation electrode (radius = 75 μm) as evaluated in section 2.1.3.2 of chapter
2 (Newman 1966). The level of stimulation performed on the neural probe was
far under the safety limit as deﬁned per the study of Shannon (R. V. Shannon
1992). We therefore didn’t expect having produced any damages to the neurons
during the stimulation periods.
5.5 Conclusions
In the ﬁrst part of this chapter was provided a model describing the droplet
evaporation behavior as well as a model characterizing the species diffusion into
the perfusate drop. In summary, the outcomes of this ﬁrst section are:
• An analytic description validated experimentally of the mixed behavior
observed during droplet evaporation in presence of PFD (ﬁrst CCA mode
then CWA mode)
• A description of the species diffusion which takes place in the perfusate
drop. This model allows to link the droplet sampling rate to the relative
recovery of the neural probe
With these two models, it is now possible to retrieve the actual tissues concen-
tration in direct proximity to the probe sampling inlet from the detection results,
even if the dried spot is partially analyzed.
The second section of this chapter presented a method for simultaneously record
neurochemical activity and electrically stimulate in the cerebral tissues in rats
brain. Three sets of brain-ﬂuid samples were successfully collected and analyzed
using ICP mass spectrometry. The main outcomes of this second in vivo study are:
• The K+ ion concentration signiﬁcantly increased during electrical stim-
ulation periods. This result was conﬁrmed on each of the 3 implanted
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animals.
• The Pt signal signiﬁcantly increased during electrical stimulation as well,
which makes it a good "marker" of the stimulation periods.
• The cerebral tissues seemed to be placed in a hyperpolarized state as
a reaction to the electrical stimulation, which is consistent with the K+
increase measured.
It is equally important to note that other species have been found in signiﬁcant
quantities on the samples analyzed. In particular Na, Mg, K and Ca were found in
every sets of droplets, conﬁrming the results of the precedent in vivo study results
(chapter 4). Metal traces were also detected for the Fe, Cu and the Zn although
the signal was generally lower than reported in chapter 4.
115

Chapter 6
Conclusions and Future
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The objective of this work is to contribute to the ﬁeld of neurotechnology and
neurophysiology by providing new strategies of interaction with the cerebral
tissues. A major effort was provided to combine an efﬁcient ﬂuidic collection
system with an electrical stimulation platform on a same device, using microtech-
nology approaches. Such a system allows to provide a more reliable technique
for performing neurophysiological studies in comparison with existing solutions.
In summary, this thesis brought the following outcomes:
• Neural probe microfabrication
Microfabrication methods have been shown to enable the production of a
minimally invasive device (needle-like) comprising a microﬂuidic network
(channel cross sections: 40 x 80 μm2) as well as microelectrodes. The
use of polymer materials such as polyimide combined with noble metals
(platinum and titanium) allowed to produce a ﬂexible, biocompatible neural
probe. The fabrication approach enabled to integrate a compact micro-
droplet generation system at the distal tip of the probe. In addition to
being compatible with high temporal resolution sampling of in vivo ﬂuid,
this sampling mechanism is proposed as a novel approach solving Taylor
dispersion that usually occurs in non-segmented ﬂow.
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• Device performances
The ex vivo assessment of the main neural probe functions allowed to
guarantee that its behavior was compatible with the intended ﬁeld of use.
In particular, the mechanical stiffness of the probe was shown to be high
enough to withstand penetration in cerebral cortex while remaining ﬂexible.
The electrical behavior of the probe was thoroughly assessed by impedance
spectroscopy and the probe was experimentally demonstrated to reach a
collection frequency as high as 6Hz (meaning one droplet every 170ms).
This result largely overcomes the typical temporal resolution reached by
microdialysis (ca. 10min) and renders the system compatible with the time
range of fast synaptic signal transmission (< second).
• In vivo pilot animal study
The neural probe was successfully tested in vivo as part of a pilot animal trial
performed on rats. The device was inserted in the Striatum of a rat brain and
collected brain-ﬂuid samples organized in droplet trains. The implantation
procedure and the system functions (such as the ﬂuidic control) were shown
to be well compatible with the surgery setup. Histological study performed
on brain tissue sections post implantation demonstrated minimal tissue
damage around the probe track.
• A platform for samples analysis
A custom analysis platform enabling the detection of the brain-ﬂuid sam-
ples was developed. The proposed approach consisted in the sequential
distribution of the collected samples on a microfabricated target plate, main-
taining spatial separation and order between droplets, thus guarantying
the time-history of the sampling. ICP mass spectroscopy allowed to detect
Na, Mg, K and Ca in signiﬁcant quantities, reﬂecting the neurochemical
content of the brain extracellular space. The method was further proven to
be quantitative and allowed to measure consistent concentration values for
Fe, Cu and Zn. The established method of detection gave access to a broad
range of information regarding the neurochemical state of the implanted
medium.
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A mathematical description of the droplet drying process and the in vivo
species diffusion provided a method for retrieving the actual tissue concen-
tration (volume concentration) from the analysis output (surface concentra-
tion). The dependence between the probe relative recovery and the droplet
sampling rate was assessed using the models. With our system, relative re-
covery which overpasses 75% is predicted by adjusting the sampling period
to 30 s (0.03Hz).
• 2nd In vivo animal study
A second in vivo animal study involving 3 different subjects allowed to
record the neurochemical activity of the cerebral tissues during 20min in-
cluding during electrical stimulation periods. The results demonstrated an
increased neurochemical activity in response to the electrical stimulation.
In particular, a rise in the K+ ion concentration during electrical stimulation
was conﬁrmed in each of the 3 implanted animals. The electrical stimu-
lation seem to have set the neurons in a permanent hyperpolarized state,
provoking a K+ ions efﬂux out of the cells.
The high temporal resolution was deﬁned as a major speciﬁcation of the neural
probe. This placed considerable constraints on the design process as well as on the
microﬂuidic driving control. The mathematical models implemented in chapter 5
highlighted the diluting effect of the perfusion on the species present in cerebral
tissues; indeed, the larger the exchange zone (or the perfusate drop), the lower
is the probe relative recovery. This pointed out the existing tradeoff between the
temporal resolution and the desired relative recovery value. At usual dialysate
ﬂow rates (e.g. 1 μL/min), standard microdialysis relative recovery values remain
under 40% (Chefer et al. 2009). The developed in vivo diffusion model predicts a
relative recovery above 50% with a sampling frequency set to 0.1Hz leading to a
temporal resolution of 10 s. The latter is largely above the actual microdialysis
performance (c.a. 10min) which, today, is mainly limited by the resolution of
the analysis method (Kennedy 2013). However, the model description did not
consider the continuous renewal of the perfusate drop; the system was assumed
to be in steady state which is an approximation. The model prediction could
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be further improved by considering a source and a sink nearby the sampling
spot. Considering these elements, one may claim that a high temporal resolution
sampling only makes sense if the perfusion drop volume is drastically decreased
(which implies a tight link with the tissues) and/or the perfusion ﬂow rate is
maintained at a slow level.
The material choices had an impact on the mechanical behavior of the probe
shank. The use of polymers (Polyimide, SU-8 resin) allowed to provide a rather
ﬂexible structure which was moreover proven to be rigid enough to be inserted in
the cerebral tissues. In case of a long-term implantation use, mechanically ﬂexible
brain interfaces are known to reduce tissue inﬂammation and ﬁbrosis, as they
better match the viscoelastic properties of cerebral tissues (Mercanzini, Colin, et al.
2009; Minev et al. 2015). Yet, in our study, the neural probe was used in an acute
application with a maximum implantation time of two hours. One may argue that
a rigid structure would have been more appropriate and lead to the same results.
Silicon-based probe including microchannels and microelectrodes have indeed
been used for drug delivery applications (J. Chen et al. 1997; H. J. Lee et al. 2015).
The mechanical rigidity of these solutions facilitate the physical connection of
external equipment on the probe (e.g. electrical and ﬂuidic interfaces). However,
the brittle characteristic of silicon renders it poorly compatible with handling
during implantation; the sharp edges of silicon also remain a traumatic aspect for
the tissues. Another point relates to the droplet sampling process. The surface
properties of the microchannel play a decisive role for the proper handling of a
droplet-segmented ﬂow. Silicon microchannels are generally created by Deep-
Reactive Ion Etching (DRIE) resulting in rather hyrophilic-like surface properties.
This situation is not recommended in our case since aqueous droplets are carried
in an oil phase (PFD) which requires hydrophobic channel walls. With respect to
all these aspects, the choice of polymer-based and mechanically ﬂexible materials
seems reasonable.
The simultaneous electrical stimulation and neurochemical sampling allowed to
detect signiﬁcant changes in K+ concentration in the cerebral tissues. As a ﬁrst
approach, we computed the maximum relative abundance found over each dried
spot and analyzed these data. Computing the mean dried spot intensity over
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the dried spot surface instead could certainly contribute to reﬁne the analysis by
averaging the occasional non-uniform distribution of the concentration peaks.
Additionally, a quantitative analysis of the data should allow to derive the surface
concentration values (dried spots) leading to a reasonable estimation of the
actual cerebral tissue volume concentration. This would request a supplementary
experimental step to deﬁne the calibration curves but would also offer valuable
information.
6.1 Outlooks
The main contribution of this thesis is to provide a device for the precise recording
of neurochemical activity in response to electrical stimulation with a dedicated
analytic platform. The extension of the detection method to Matrix Assisted Laser
Desorption/Ionisation (MALDI) mass spectrometry would represent a signiﬁcant
increment, giving access to a large number of biomolecules including proteins and
neurotransmitters. α-Synuclein is a presynaptic protein which may contribute to
the pathophysiology of PD by its a toxic effect ultimately leading to the death of
dopaminergic neurons (Stefanis 2012). The in vivo detection of α-synuclein con-
centration evolution over time in electrically stimulated PD animal models would
certainly provide interesting perspectives regarding disease pathophysiological
mechanisms and the impact of DBS.
The monitoring of neurotransmitter concentration changes locally triggered by
electrical stimulation would be equally interesting for the early detection of
neurological disorders. In particular the Da level in response to stimulation at
several time steps of PD evolution could lead to a better characterization of the
disease. Such new approaches could open the doors to the development of better
diagnostic tools leading to earlier disorder detection. These approaches could
have a profound medical impact, as early PD treatment is more effective and
result in a prolonged quality of life for the affected patients (Noyes et al. 2013;
Pahwa et al. 2010; Hauser 2009).
On the actual device, the sample analysis is performed post implantation, in
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a second step. In a near future, it will probably be possible to implement the
neurochemical detection in real time, on the same device. This could lead to
more efﬁcient electrical stimulation therapy of the CNS and PNS by using a
closed-loop system control. A major step towards this direction would be to
adjust the electrical stimulation pattern delivered in a DBS target such as the STN
while optimizing the elicited neurochemical response with the best therapeutic
effect.
Another major clinical application of this technology is related to the analysis of
seizure focal zones during epilepsy treatment. Surgical management of epilepsy
involves electrical brain mapping performed using electrodes to detect the focal
position of the seizures and their relative proximity to important neural functions
(speech, vision, sensory, motor, etc). The use of the neural probe intraopera-
tively could here facilitate the localization of the seizure focal point by detecting
biomarkers associated with epilepsy (Jerome et al. 2014). Such approach would
allow the surgeon to be more precise and thus preserve larger zones of functional
cerebral tissues resulting in a direct beneﬁt for the patient.
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Appendix A
Appendix
A.1 Probe Electrical Pairing Chart
1
2
3
4
5
6
7
8
(a)
(b)
proximal
distal
Figure A.1 Chart of the pairing between the proximal contacts and the distal electrodes. (a)
general view of the probe including the proximal and distal region. (b) Detail of the pairing.
Each distal electrode is attributed to a proximal contact.
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Appendix A. Appendix
A.2 Electrical Stimulation Pattern
60 s 
(train pulse duration)
2 ms 2 ms
17 ms
300 μA
Figure A.2 Detail of the electrical stimulation performed during the second in vivo
experiment. Train of biphasic pulses of 300 μA amplitude and 2ms duration at a frequency
of 60Hz were delivered during 60 sec.
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